Figures
  • US20100216250A1-20100826-D00000
  • US20100216250A1-20100826-D00001
  • US20100216250A1-20100826-D00002
Abstract
The present invention relates to biomarkers in maternal serum samples and methods for predicting whether a fetus has Trisomy 21 during the first trimester of pregnancy based on the differential expression of a combination, or subcombination, of the same.
Claims
What is claimed is:
1. A method for predicting whether a fetus has Trisomy 21, comprising the steps of:
(a) measuring the expression level of a peptide fragment of at least one target protein selected from the group consisting of apolipoprotein A-I preprotein, apolipoprotein A-II preprotein, apolipoprotein A-IV precursor, apolipoprotein B precursor, apolipoprotein C-I precursor, apolipoprotein C-II precursor, apolipoprotein C-III precursor, apolipoprotein D precursor, apolipoprotein E precursor, apolipoprotein H precursor, paraoxonase 1, pregnancy-zone protein, α-2-macroglobulin precursor, serum amyloid A4, serum amyloid P component precursor, β-globin, ceruloplasmin precursor, α-1 globin and histidine-rich glycoprotein precursor in a serum sample obtained from the mother of the fetus during the first trimester of pregnancy, wherein the expression level is measured using tandem mass spectrometry; and
(b) comparing the expression level of the peptide fragment in the sample to a corresponding control level, wherein a difference in the expression level of the peptide fragment in the sample relative to the corresponding control level is predictive of a fetus having Trisomy 21.
2. The method of claim 1, wherein the peptide fragment is selected from the group consisting of SEQ ID NO:45, SEQ ID NO:98, SEQ ID NO:161, SEQ ID NO:175, SEQ ID NO:177, SEQ ID NO:221, SEQ ID NO:226, SEQ ID NO:233, SEQ ID NO:242, SEQ ID NO:243, SEQ ID NO:246, SEQ ID NO:249, SEQ ID NO:253, SEQ ID NO:254, SEQ ID NO:258, SEQ ID NO:265, SEQ ID NO: 267, SEQ ID NO:268, and SEQ ID NO:278.
3. The method of claim 2, wherein the peptide fragment is SEQ ID NO:258 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 942→387, 942→516, 942→603, 942→771, 942→812, 942→868, 942→982, 942→1199, and 942→1314.
4. The method of claim 2, wherein the peptide fragment is SEQ ID NO:175 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 510→179, 510→244, 510→357, 510→424, 510→474, 510→520, 510→534, 510→747, and 510→847.
5. The method of claim 2, wherein the peptide fragment is SEQ ID NO:254 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 543→329, 543→343, 543→372, 543→456, 543→514, 543→543, 543→656, 543→743, and 543→891.
6. The method of claim 2, wherein the peptide fragment is SEQ ID NO:98 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 567→232, 567→363, 567→410, 567→467, 567→478, 567→535, 567→634, 567→691, and 567→819.
7. The method of claim 2, wherein the peptide fragment is SEQ ID NO:177 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 579→232, 579→345, 579→436, 579→508, 579→621, 579→708, 579→871, 579→1001, and 579→1058.
8. The method of claim 2, wherein the peptide fragment is SEQ ID NO:242 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 638→303, 638→404, 638→426, 638→475, 638→525, 638→687, 638→850, 638→949, and 638→1049.
9. The method of claim 2, wherein the peptide fragment is SEQ ID NO:267 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 686→331, 686→541, 686→622, 686→670, 686→783, 686→871, 686→984, and 686→1081.
10. The method of claim 2, wherein the peptide fragment is SEQ ID NO:221 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 612→443, 612→464, 612→475, 612→524, 612→589, 612→663, 612→712, 612→785, 612→813, 612→927, 612→1041, and 612→1189.
11. The method of claim 2, wherein the peptide fragment is SEQ ID NO:278 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 563→201, 563→288, 563→339, 563→395, 563→401, 563→477, 563→529, 563→676, and 563→789.
12. The method of claim 2, wherein the peptide fragment is SEQ ID NO:45 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 512→304, 512→327, 512→361, 512→376, 512→426, 512→489, 512→652, 512→751, and 512→850.
13. The method of claim 2, wherein the peptide fragment is SEQ ID NO:246 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 507→260, 507→328, 507→373, 507→427, 507→444, 507→654, 507→741, 507→855, and 507→912.
14. The method of claim 2, wherein the peptide fragment is SEQ ID NO:253 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 450→226, 450→288, 450→377, 450→451, 450→566, and 450→752.
15. The method of claim 2, wherein the peptide fragment is SEQ ID NO:268 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 807→482, 807→569, 807→670, 807→769, 807→856, 807→971, 807→1158, 807→1272, and 807→1387.
16. The method of claim 2, wherein the peptide fragment is SEQ ID NO:226 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 599→260, 599→347, 599→434, 599→477, 599→581, 599→638, 599→753, 599→854, and 599→953.
17. The method of claim 2, wherein the peptide fragment is SEQ ID NO:233 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 647→262, 647→389, 647→504, 647→591, 647→605, 647→719, 647→776, 647→923, and 647→1052.
18. The method of claim 2, wherein the peptide fragment is SEQ ID NO:243 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 616→246, 616→361, 616→474, 616→502, 616→588, 616→702, 616→789, 616→890, and 616→1004.
19. The method of claim 2, wherein the peptide fragment is SEQ ID NO:249 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 579→260, 579→286, 579→373, 579→470, 579→471, 579→535, 579→684, 579→813, and 579→942.
20. The method of claim 2, wherein the peptide fragment is SEQ ID NO:265 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 603→466, 603→536, 603→546, 603→565, 603→580, 603→623, 603→701, 603→736, and 603→770.
21. The method of claim 2, wherein the peptide fragment is SEQ ID NO:161 and wherein the expression level of the peptide fragment is measured by selective reaction monitoring (SRM) tandem mass spectrometry using an m/z transition selected from the group consisting of about 644→305, 644→434, 644→436, 644→536, 644→620, 644→783, 644→870, 644→957, and 644→1071.
22. The method of claim 1, wherein the sample is enriched for peptide fragments bound to carrier proteins prior to mass spectrometry.
23. The method of claim 1, wherein the sample is reduced, alkylated and desalted prior to mass spectrometry.
24. The method of claim 1, wherein the sample is subjected to one dimensional SDS-polyacrylamide gel electrophoresis prior to mass spectrometry.
25. The method of claim 1, wherein the sample is subjected to isoelectric focusing prior to mass spectrometry.
26. The method of claim 1, wherein proteins from the sample are subjected to trypsin proteolysis prior to mass spectrometry.
27. The method of claim 1, wherein proteins from the sample are subjected to liquid chromatography prior to mass spectrometry.
28. The method of claim 1, wherein the tandem mass spectrometry is electrospray ionization tandem mass spectrometry.
29. The method of claim 28, wherein the electrospray ionization tandem mass spectrometry is performed using a quadrapole mass spectrometer.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the priority benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 61/154,267 by Lopez et al., the entire disclosure of which is incorporated herein by reference.
BACKGROUND OF THE INVENTION
[0002] Trisomy 21, or Down's syndrome, is the most frequent fetal chromosomal disorder affecting pregnant women, and is one of the most common serious congenital abnormalities found at birth (Jones, K., Down's Syndrome in Smith's recognizable patterns of human malformation, Jones, K., Editor, 1997, Philadelphia, Pa., pp. 8-13). A majority of infants born with Down's syndrome will have serious cardiac, gastrointestinal, or other abnormalities that lead to significant morbidity and mortality. In addition, Down's syndrome is one of the leading causes of mental deficiency in the United States.
[0003] Down's syndrome occurs at a rate of 1 in 600-800 pregnancies and prompts most prenatal diagnoses that involve potentially dangerous invasive procedures such as amniocentesis or chorionic villous sampling. These procedures carry a significant risk of miscarriage and therefore are typically only applied to women in high risk groups (Zournatzi V, Daniilidis A, Karidas C, Tantanasis T, Loufopoulos A, Tzafettas J. 2008 Hippocratia 1: 28-32).
[0004] In an effort to reduce the frequency of invasive screening procedures, non-invasive procedures, such as maternal blood tests that measure protein biomarkers associated with Down's syndrome in maternal serum samples, and ultrasonographic measurements of nuchal translucency and other defects (Kagan K O, Wright D, Spencer K, Molina F S, Nicolaides K H. 2008 Ultrasound Obstet. Gynecol. 5:493-502), are routinely offered to pregnant women for second trimester screening. However, the sensitivity and specificity of these tests remains limited. Moreover, the effectiveness of these procedures for diagnosing Trisomy 21 during the first trimester of pregnancy has not been sufficiently validated.
[0005] Thus, despite the availability of several screening procedures for Down's syndrome, there is a significant need for new, safe and effective biomarkers and non-invasive screening methods for diagnosing Down's syndrome, particularly during the early stages of pregnancy.
SUMMARY OF THE INVENTION
[0006] The present invention is based, in part, on Applicants' discovery of a panel of differentially expressed proteins in maternal serum obtained during the first trimester of pregnancy, wherein the expression level of one or more of the proteins (or peptide fragments derived therefrom) is predictive of a Trisomy 21 fetus.
[0007] In one embodiment, the invention relates to a method for predicting whether a fetus has Trisomy 21. The method comprises the step of measuring the expression level of a signature peptide fragment of at least one target protein (e.g., a peptide fragment characteristic of the target protein), wherein the target protein is selected from the group consisting of apolipoprotein A-I preprotein, apolipoprotein A-II preprotein, apolipoprotein A-IV precursor, apolipoprotein B precursor, apolipoprotein C-I precursor, apolipoprotein C-II precursor, apolipoprotein C-III precursor, apolipoprotein D precursor, apolipoprotein E precursor, apolipoprotein H precursor, paraoxonase 1, pregnancy-zone protein, α-2-macroglobulin precursor, serum amyloid A4, serum amyloid P component precursor, β-globin, ceruloplasmin precursor, α-1 globin and histidine-rich glycoprotein precursor in a serum sample obtained from the mother of the fetus during the first trimester of pregnancy. According to a preferred embodiment of the invention, the expression level is measured using tandem mass spectrometry. The method also comprises the step of comparing the expression level of the signature peptide fragment(s) in the sample to a corresponding control level(s). A difference (i.e., an increase or decrease) in the expression level of the signature peptide fragment(s) in the sample relative to the corresponding control level(s) is predictive of a fetus having Trisomy 21.
[0008] In a particular embodiment, the peptide fragment in the maternal serum sample is one or more selected from the group consisting of SEQ ID NO:45, SEQ ID NO:98, SEQ ID NO:161, SEQ ID NO:175, SEQ ID NO:177, SEQ ID NO:221, SEQ ID NO:226, SEQ ID NO:233, SEQ ID NO:242, SEQ ID NO:243, SEQ ID NO:246, SEQ ID NO:249, SEQ ID NO:253, SEQ ID NO:254, SEQ ID NO:258, SEQ ID NO:265, SEQ ID NO: 267, SEQ ID NO:268, and SEQ ID NO:278.
[0009] In another embodiment, the maternal serum sample is subjected to one or more of the following steps prior to mass spectrometry: enrichment for peptide fragments bound to carrier proteins; sample reduction, alkylation and/or desalting; one dimensional SDS-polyacrylamide gel electrophoresis; trypsin proteolysis; or liquid chromatography.
[0010] As described herein, a combination or subcombination (i.e., a panel) of all or any number of these target proteins, or their signature peptide fragments, in first trimester maternal serum are useful predictors of a Trisomy 21 fetus. The present invention provides a non-invasive and safe prenatal screening method for predicting whether a fetus has Trisomy 21. The methods of the invention have the advantage of providing a diagnosis of Trisomy 21 at an earlier stage of pregnancy than many commonly practiced Trisomy 21 screening methods.
BRIEF DESCRIPTION OF THE DRAWINGS
[0011] FIG. 1 is a workflow diagram depicting an exemplary process for identifying biomarkers of Trisomy 21 in maternal serum samples, including sample collection, preparation, and analysis steps, and verification of candidates.
[0012] FIG. 2 is a workflow diagram depicting an exemplary process for LC MS/MS analysis of biomarkers in maternal serum samples and subsequent processing of analytical data.
DETAILED DESCRIPTION OF THE INVENTION
[0013] As described herein, Applicants have identified biomarkers that are differentially expressed in biological samples from first trimester pregnant females carrying a fetus who has Trisomy 21, relative to biological samples from first trimester pregnant females carrying a fetus who does not have Trisomy 21. Accordingly, the expression levels of such biomarkers can be used to predict whether a fetus has Trisomy 21 during the first trimester of pregnancy.
[0014] In one embodiment, the invention relates to a method for predicting whether a fetus has Trisomy 21. The method comprises the step of measuring the expression level of a peptide fragment (e.g., one or more peptide fragments) of at least one target protein selected from the group consisting of apolipoprotein A-I preprotein (NCBI Accession NP000030.1), apolipoprotein A-II preprotein (NCBI Accession NP001634.1), apolipoprotein A-IV precursor (NCBI Accession NP000473.2), apolipoprotein B precursor (NCBI Accession NP000375.2), apolipoprotein C-I precursor (NCBI Accession NP001636.1), apolipoprotein C-II precursor (NCBI Accession NP000474.2), apolipoprotein C-III precursor (NCBI Accession NP000031.1), apolipoprotein D precursor (NCBI Accession NP001638.1), apolipoprotein E precursor (NCBI Accession NP000032.1), apolipoprotein H precursor (NCBI Accession NP000033.1), paraoxonase 1 (NCBI Accession NP000437.3), pregnancy-zone protein (NCBI Accession NP002855.1), α-2-macroglobulin precursor (NCBI Accession NP000005.2), serum amyloid A4 (NCBI Accession NP006503.1), serum amyloid P component precursor (NCBI Accession NP001630.1), β-globin (NCBI Accession NP000509.1), ceruloplasmin precursor (NCBI Accession NP000087.1), α-1 globin (NCBI Accession NP000549.1) and histidine-rich glycoprotein precursor (NCBI Accession NP000403.1).
[0015] As used herein, the term “peptide fragment” generally refers to any fragment of a full-length naturally-occurring target protein (e.g., a fragment produced by proteoytic digestion). The peptide fragment can be of any size, provided that the peptide fragment is smaller (i.e., has fewer amino acids) than the full-length target protein. In a preferred embodiment, a peptide fragment has a size in the range of about 5 to about 25 amino acids. In a particular embodiment, a peptide fragment has a size in the range of about 6 to about 17 amino acids.
[0016] In one embodiment, the methods of the invention comprise measuring the expression level of a peptide fragment selected from the group consisting of SEQ ID NO:45, SEQ ID NO:98, SEQ ID NO:161, SEQ ID NO:175, SEQ ID NO:177, SEQ ID NO:221, SEQ ID NO:226, SEQ ID NO:233, SEQ ID NO:242, SEQ ID NO:243, SEQ ID NO:246, SEQ ID NO:249, SEQ ID NO:253, SEQ ID NO:254, SEQ ID NO:258, SEQ ID NO:265, SEQ ID NO: 267, SEQ ID NO:268, and SEQ ID NO:278 in a biological sample obtained from a pregnant female.
[0017] In a particular embodiment, the peptide fragment is SEQ ID NO:258 and the level of expression of the biomarker protein (paraoxanase 1) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 942→387, 942→516, 942→603, 942→771, 942→812, 942→868, 942→982, 942→1199, and 942→1314.
[0018] In another embodiment, the peptide fragment is SEQ ID NO:175 and the level of expression of the biomarker protein (pregnancy-zone protein) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 510→179, 510→244, 510→357, 510→424, 510→474, 510→520, 510→534, 510→747, and 510→847.
[0019] In a further embodiment, the peptide fragment is SEQ ID NO:254 and the level of expression of the biomarker protein (alpha-2-macroglobulin precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 543→329, 543→343, 543→372, 543→456, 543→514, 543→543, 543→656, 543→743, and 543→891.
[0020] In an additional embodiment, the peptide fragment is SEQ ID NO:98 and the level of expression of the biomarker protein (serum amyloid A4) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 567→232, 567→363, 567→410, 567→467, 567→478, 567→535, 567→634, 567→691, and 567→819.
[0021] In another embodiment, the peptide fragment is SEQ ID NO:177 and the level of expression of the biomarker protein (serum amyloid P component precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 579→232, 579→345, 579→436, 579→508, 579→621, 579→708, 579→871, 579→1001, and 579→1058.
[0022] In yet another embodiment, the peptide fragment is SEQ ID NO:242 and the level of expression of the biomarker protein (beta globin) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 638→303, 638→404, 638→426, 638→475, 638→525, 638→687, 638→850, 638→949, and 638→1049.
[0023] In another embodiment, the peptide fragment is SEQ ID NO:267 and the level of expression of the biomarker protein (ceruloplasmin precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 686→331, 686→541, 686→622, 686→670, 686→783, 686→871, 686→984, and 686→1081.
[0024] In an additional embodiment, the peptide fragment is SEQ ID NO:221 and the level of expression of the biomarker protein (alpha 1 globin) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 612→443, 612→464, 612→475, 612→524, 612→589, 612→663, 612→712, 612→785, 612→813, 612→927, 612→1041, and 612→1189.
[0025] In a further embodiment, the peptide fragment is SEQ ID NO:278 and the level of expression of the biomarker protein (histidine-rich glycoprotein precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 563→201, 563→288, 563→339, 563→395, 563→401, 563→477, 563→529, 563→676, and 563→789.
[0026] In another embodiment, the peptide fragment is SEQ ID NO:45 and the level of expression of the biomarker protein (apolipoprotein H precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 512→304, 512→327, 512→361, 512→376, 512→426, 512→489, 512→652, 512→751, and 512→850.
[0027] In yet another embodiment, the peptide fragment is SEQ ID NO:246 and the level of expression of the biomarker protein (apolipoprotein B precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 507→260, 507→328, 507→373, 507→427, 507→444, 507→654, 507→741, 507→855, and 507→912.
[0028] In a further embodiment, the peptide fragment is SEQ ID NO:253 and the level of expression of the biomarker protein (apolipoprotein E precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 450→226, 450→288, 450→377, 450→451, 450→566, and 450→752.
[0029] In another embodiment, the peptide fragment is SEQ ID NO:268 and the level of expression of the biomarker protein (apolipoprotein A-I preprotein) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 807→482, 807→569, 807→670, 807→769, 807→856, 807→971, 807→1158, 807→1272, and 807→1387.
[0030] In an additional embodiment, the peptide fragment is SEQ ID NO:226 and the level of expression of the biomarker protein (apolipoprotein C-III precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 599→260, 599→347, 599→434, 599→477, 599→581, 599→638, 599→753, 599→854, and 599→953.
[0031] In further embodiment, the peptide fragment is SEQ ID NO:233 and the level of expression of the biomarker protein (apolipoprotein C-I precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 647→262, 647→389, 647→504, 647→591, 647→605, 647→719, 647→776, 647→923, and 647→1052.
[0032] In another embodiment, the peptide fragment is SEQ ID NO:243 and the level of expression of the biomarker protein (apolipoprotein D precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 616→246, 616→361, 616→474, 616→502, 616→588, 616→702, 616→789, 616→890, and 616→1004.
[0033] In yet another embodiment, the peptide fragment is SEQ ID NO:249 and the level of expression of the biomarker protein (apolipoprotein A-II preprotein) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 579→260, 579→286, 579→373, 579→470, 579→471, 579→535, 579→684, 579→813, and 579→942.
[0034] In an additional embodiment, the peptide fragment is SEQ ID NO:265 and the level of expression of the biomarker protein (apolipoprotein A-IV precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 603→466, 603→536, 603→546, 603→565, 603→580, 603→623, 603→701, 603→736, and 603→770.
[0035] In a further embodiment, the peptide fragment is SEQ ID NO:161 and the level of expression of the biomarker protein (apolipoprotein C-II precursor) corresponding to the peptide fragment is measured by SRM mass spectrometry using an m/z transition selected from the group consisting of about 644→305, 644→434, 644→436, 644→536, 644→620, 644→783, 644→870, 644→957, and 644→1071.
[0036] It will be recognized that the m/z values specified above are nominal (rounded integer) values and are therefore approximate, and that the preferred embodiments of the invention include the use of transitions that have precursor/product ion m/z's that are within ±0.5 of the foregoing values.
[0037] Although the methods of the invention are exemplified herein using peptide fragments of the target proteins apolipoprotein A-I preprotein, apolipoprotein A-II preprotein, apolipoprotein A-IV precursor, apolipoprotein B precursor, apolipoprotein C-I precursor, apolipoprotein C-II precursor, apolipoprotein C-III precursor, apolipoprotein D precursor, apolipoprotein E precursor, apolipoprotein H precursor, paraoxonase 1, pregnancy-zone protein, α-2-macroglobulin precursor, serum amyloid A4, serum amyloid P component precursor, β-globin, ceruloplasmin precursor, α-1 globin and histidine-rich glycoprotein precursor, the invention can also be practiced by measuring and comparing expression levels of the full-length target proteins.
[0038] As used herein, the terms “one or more” and “at least one” in the context of peptide fragments, biomarkers, and target proteins mean any one, two, three, four, etc. of the listed members within a group, in any permutation. Accordingly, the terms “one or more” and “at least one” include any two, any three, any four, etc. of the members specifically listed within a group. Thus, the invention is not limited to any single group or subset of biomarkers. It is emphasized that the terms “one or more” and “at least one” are used in the broadest sense, and are used to designate any subgroup within a group with multiple members. Similarly, the terms “at least 2,” “at least 3,” “at least 4,” etc., cover any combinations of the members within a particular group, provided that the total number of members within the combination is at least 3, at least 3, at least, 4, etc.
[0039] Target proteins suitable for use in the methods of the invention are listed in Tables 1 and 2. Preferred biomarker m/z transitions are listed in Table 2. Any combination of one or more of the biomarkers listed in Tables 1 and 2 can be used in the methods of the invention.
[0040] A combination of different biomarkers (e.g., signature peptide fragments), as described above, might significantly improve diagnostic accuracy. For example, individual biomarkers can typically detect Down's syndrome in about 30% to 80% of occurrences. Using a combination of biomarkers, a diagnostic sensitivity and specificity of anywhere between 80% and 98% may be achieved. A combination of biomarkers which act independently, through distinct biological pathways, is particularly advantageous, as such combinations are expected to significantly increase diagnostic specificity and sensitivity.
[0041] The screening methods of the invention can also be combined with existing screening techniques for the detection of Trisomy 21. Thus, the diagnostic methods described herein can be combined with an examination of one or more known biomarkers for Trisomy 21, such as, for example, one or more of serum biomarkers PAPP-A, α-fetoprotein (AFP), human chorionic gonadotropin (βhCG), unconjugated estriol (uE3), and inhibin A. In a particular embodiment, the present screening techniques can be combined with a test using PAPP-A and βhCG as independent biomarkers, or a triple-marker serum test, based on AFP, βhCG, and uE3, especially if screening is performed in the second trimester. The test might, additionally or alternatively, include inhibin-A.
[0042] The screening assays described herein can further be combined with or supplemented by other techniques used to detect Trisomy 21 including, but not limited to, ultrasonography (e.g., transabdominal ultrasonography, translucent ultrasonography), nuchal translucency (NT) measurement, and techniques for detecting chromosomal abnormalities known in the art (e.g., karyotyping).
[0043] The expression level (e.g., amount, quantity, abundance) of one or more peptide fragments of any target protein identified herein can be measured in a biological sample obtained from a pregnant female. Suitable maternal biological samples for use in the methods of the invention include, for example, a serum sample, a plasma sample, a blood sample, an amniotic fluid sample, a urine sample, a cerebrospinal fluid sample, a breast milk sample, a mucus sample, and a saliva sample. In a preferred embodiment, the biological sample is a maternal serum sample.
[0044] The biological sample can be obtained from the mother at any time during pregnancy (e.g., first trimester, second trimester, third trimester). In a preferred embodiment, the biological sample is obtained from the mother during the first trimester of pregnancy.
[0045] The level of a peptide fragment of any target protein identified herein can be determined using any suitable analytical technique known in the art for identifying protein or peptide levels in a biological sample. Such methods include, but are not limited to, mass spectrometry, immunoblot analysis, immunohistochemical methods (e.g., in situ methods based on antibody detection of a target protein or peptide in a biological sample), immunoassays (e.g., ELISA), protein microarray methods and electrophoretic methods (e.g., 2-dimensional gel electrophoresis).
[0046] In a preferred embodiment, mass spectrometry (e.g., electrospray ionization or ESI mass spectrometry) is used to determine the expression level of one or more peptides in a maternal sample. The terms “mass spectrometry” or “MS” as used herein refer to methods of filtering, detecting, and measuring ions based on their mass-to-charge ratio, or “m/z.” In general, mass spectrometry involves ionizing a sample containing one or more molecules of interest, and then m/z separating and detecting the resultant ions (or product ions derived therefrom) in a mass analyzer, such as, without limitation, a quadrupole mass filter, quadrupole ion trap, time-of-flight analyzer, FT/ICR analyzer or Orbitrap, to generate a mass spectrum representing the abundances of detected ions at different values of m/z. See, e.g., U.S. Pat. No. 6,204,500, entitled “Mass Spectrometry From Surfaces;” U.S. Pat. No. 6,107,623, entitled “Methods and Apparatus for Tandem Mass Spectrometry;” U.S. Pat. No. 6,268,144, entitled “DNA Diagnostics Based On Mass Spectrometry;” U.S. Pat. No. 6,124,137, entitled “Surface-Enhanced Photolabile Attachment And Release For Desorption And Detection Of Analytes;” Wright et al., “Protein chip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures,” Prostate Cancer and Prostatic Diseases 2: 264-76 (1999); and Merchant and Weinberger, “Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry,” Electrophoresis 21: 1164-67 (2000), each of which is hereby incorporated by reference in its entirety, including all tables, figures, and claims.
[0047] In a particular embodiment, tandem mass spectrometry (e.g., using a quadrapole mass spectrometer) is employed in the methods of the invention. As used herein “tandem mass spectrometry,” or “MS/MS” refers to a technique wherein a precursor ion or group of ions generated from a molecule (or molecules) of interest may be isolated or selected in an MS instrument, and these precursor ions subsequently fragmented to yield one or more fragment ions that are then analyzed in a second MS procedure. By careful selection of precursor ions, ions produced by certain analytes of interest are selectively passed to the fragmentation chamber, where collision with atoms or molecules of an inert gas occurs to produce the fragment ions. Because both the precursor and fragment ions are produced in a reproducible fashion under a given set of ionization/fragmentation conditions, the MS/MS technique can provide an extremely powerful analytical tool. For example, the combination of filtration/fragmentation can be used to eliminate interfering substances, and can be particularly useful in complex samples, such as biological samples.
[0048] Ions can be produced using a variety of methods including, but not limited to, electrospray ionization (“ESI”), and matrix-assisted laser desorption ionization (“MALDI”).
[0049] In a preferred embodiment, electrospray ionization, or ESI, mass spectrometry is used to determine the expression level of one or more peptides in a maternal sample. The term “electrospray ionization,” or “ESI,” as used herein refers to methods in which a solution is passed along a short length of capillary tube, to the end of which is applied a high positive or negative electric potential. Solution reaching the end of the tube, is vaporized (nebulized) into a jet or spray of very small droplets of solution in solvent vapor. This mist of droplets flows through an evaporation chamber which is may be heated to prevent condensation and to evaporate solvent. As the droplets get smaller the electrical surface charge density increases until such time that the natural repulsion between like charges causes ions as well as neutral molecules to be released.
[0050] The term “matrix-assisted laser desorption ionization,” or “MALDI” as used herein refers to methods in which a non-volatile sample is exposed to laser irradiation, which desorbs and ionizes analytes in the sample by various ionization pathways, including photo-ionization, protonation, deprotonation, and cluster decay. For MALDI, the sample is mixed with an energy-absorbing matrix, which facilitates desorption of analyte molecules.
[0051] The term “ionization” and “ionizing” as used herein refers to the process of generating an analyte ion having a net electrical charge equal to one or more electron units. Negative ions are those ions having a net negative charge of one or more electron units, while positive ions are those ions having a net positive charge of one or more electron units.
[0052] The term “desorption” as used herein refers to the removal of an analyte from a surface and/or the entry of an analyte into a gaseous phase.
[0053] In those embodiments, such as MS/MS, where precursor ions are isolated for further fragmentation, collision-induced dissociation (“CID”) is often used to generate the fragment ions for further detection. In CID, precursor ions undergo fragmentation induced by energetic collisions with neutral molecules or atoms. Sufficient energy must be deposited in the precursor ion so that certain bonds within the ion can be broken due to increased vibrational energy.
[0054] Briefly described, the methods encompassed by the present invention include steps of acquiring a biological sample from a pregnant female (e.g., a blood serum sample collected from a woman in her first trimester of pregnancy), optionally subjecting the sample to one or more stages of preparation to modify, purify or concentrate target proteins, measuring the amounts of one or more peptide fragments characteristic of the target protein(s) by tandem mass spectrometry, and comparing the measured amount(s) to a corresponding control value or values to predict whether the fetus has Trisomy 21.
[0055] As discussed above, in various embodiments, the biological samples used in the methods of the invention are subjected to one or more sample preparation steps prior to analysis by mass spectrometry. For example, a biological sample (e.g., a serum sample) can be enriched for target proteins or biomarkers of interest using techniques known in the art. For example, target proteins or biomarkers in a serum sample can be enriched using a chromatography-based technology that relies on the Cibachron Blue dye for enrichment of peptides and protein fragments bound to carrier proteins (such as albumin) in plasma and serum samples. Such a technique is described herein in Example 1.
[0056] Prior to MS analysis, samples can also be reduced (e.g., by treatment with dithiothreitol), alkylated (e.g., by treatment with iodoacetic acid) and/or desalted (e.g., with HyperSep™-96 C18 solid phase extraction media). Methods for carrying out such steps, which can be performed with or without a sample enrichment step, are disclosed herein in the Examples.
[0057] Samples can also be subjected to further enrichment using one or more well known electrophoretic methods such as SDS PAGE or Isoelectric focusing prior to analysis by mass spectrometry. In one embodiment, samples are subjected to 1-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (“1-D SDS-PAGE”).
[0058] According to preferred embodiments, the sample is digested using a suitable proteolytic enzyme, such as trypsin, before mass spectrometric analysis. The digestion step may be performed prior or subsequent to or concurrently with other sample preparation steps. Proteolytic digestion of the sample yields peptide fragments, a portion of which will be specific to corresponding target proteins, and thus may be employed as surrogates for monitoring the quantities of the corresponding target proteins by mass spectrometry. Alternative embodiments may utilize a “top-down” approach, wherein samples containing substantially intact proteins are analyzed by mass spectrometry without first being proteolytically digested.
[0059] In a preferred embodiment, samples are subjected to a liquid chromatography (LC) purification step prior to mass spectrometry. Methods of coupling liquid chromatography techniques to MS analysis are well known and widely practiced in the art. Traditional LC analysis relies on the chemical interactions between sample components and column packings, where laminar flow of the sample through the column is the basis for separation of the analyte of interest from the test sample. The skilled artisan will understand that separation in such columns is a diffusional process.
[0060] Numerous column packings are available for chromatographic separation of samples, and selection of an appropriate separation protocol is an empirical process that depends on the sample characteristics, the analyte of interest, the interfering substances present and their characteristics, etc. Various packing chemistries can be used depending on the needs (e.g., structure, polarity, and solubility of compounds being purified).
[0061] In various embodiments the columns are polar, ion exchange (both cation and anion), hydrophobic interaction, phenyl, C-2, C-8, C-18 columns, polar coating on porous polymer, or others that are commercially available. During chromatography, the separation of materials is effected by variables such as choice of eluant (also known as a “mobile phase”), choice of gradient elution and the gradient conditions, temperature, etc.
[0062] In certain embodiments, an analyte may be purified by applying a sample to a column under conditions where the analyte of interest is reversibly retained by the column packing material, while one or more other materials are not retained. In these embodiments, a first mobile phase condition can be employed where the analyte of interest is retained by the column, and a second mobile phase condition can subsequently be employed to remove retained material from the column, once the non-retained materials are washed through. Alternatively, an analyte may be purified by applying a sample to a column under mobile phase conditions where the analyte of interest elutes at a differential rate in comparison to one or more other materials. As discussed above, such procedures may enrich the amount of one or more analytes of interest relative to one or more other components of the sample.
[0063] In a preferred embodiment, one or more LC purification steps are performed “online” with subsequent MS analysis steps. The term “online” as used herein refers to steps performed without further need for operator intervention. For example, by careful selection of valves and connector plumbing, two or more chromatography columns can be connected such that material is passed from one to the next without the need for additional manual steps. The selection and operation of valves and plumbing is controlled by a computer pre-programmed to perform the necessary steps. Preferably, the chromatography system is also connected in such an on-line fashion to the detector system, e.g., an MS system. Thus, an operator may place a tray of samples in an autosampler, and the remaining operations are performed “on-line” under computer control, resulting in purification and analysis of all samples selected.
[0064] To facilitate accurate quantitation of the peptide fragments by mass spectrometry, a set of isotopically-labeled synthetic versions of the peptide fragments of interest may be added in known amounts to the sample for use as internal standards. Since the isotopically-labeled peptides have physical and chemical properties substantially identical to the corresponding surrogate peptide, they co-elute from the chromatographic column and are easily identifiable on the resultant mass spectrum. The addition of the labeled standards may occur piro or subsequent to protolytic digestion.
[0065] In a typical implementation of the invention, quantitation of peptide fragments corresponding to targeted proteins is carried out using a triple quadrupole mass spectrometer (such as the TSQ Vantage mass spectrometer, available from Thermo Fisher Scientific) operated in selective reaction monitoring (SRM) mode. As known in the art, triple quadrupole mass spectrometers include three quadrupole rod sets. A first stage of mass selection is performed in the first quadrupole rod set, and the selectively transmitted ions are fragmented in the second quadrupole rod set. The resultant fragment (product) ions are conveyed to the third quadrupole rod set, which performs a second stage of mass selection. The product ions transmitted throught the third quadrupole rod set are measured by a detector, which generates a signal representative of the numbers of selectively transmitted product ions. The RF and DC potentials applied to the first and third quadrupoles are tuned to select (respectively) precursor and product ions that have m/z's lying within narrow specified ranges. By specifying the appropriate transitions (m/z values of precursor and product ions), a peptide corresponding to a targeted protein may be measured with high degrees of sensitivity and selectivity.
[0066] Once the mass spectrometric analysis of the prepared sample has been completed, the quantities of the peptide fragments in the sample may be determined by integration of the relevant mass spectral peak areas, as known in the prior art. When isotopically-labeled internal standards are used, as described above, the quantities of the peptide fragments of interest are established via an empirically-derived or predicted relationship between peptide fragment quantity (which may be expressed as concentration) and the area ratio of the peptide fragment and internal standard peaks at specified transitions. Other implementations of the assay may utilize external standards or other expedients for peptide quantification.
[0067] The methods of embodiments of the invention comprise the step of comparing the expression level of one or more peptide fragments in a maternal biological test sample to a corresponding control level(s). In one embodiment, the corresponding control level is the level of the peptide fragment in a corresponding normal maternal biological sample. As used herein, a “corresponding normal maternal biological sample” is a sample of the same type as the maternal test sample (e.g., a serum sample), which is obtained at the same stage of pregnancy (e.g., during the first trimester) from a mother who is not carrying a Trisomy 21 fetus (e.g. a normal control). In another embodiment, the corresponding control level is a reference standard (e.g., an average or typical level of a peptide fragment biomarker in a normal maternal biological sample based on samples obtained from a plurality (i.e., two or more) of pregnant mothers having non-Trisomy 21 pregnancies).
[0068] According to embodiments of the invention, a difference (e.g., an increase or a decrease) in the expression level of a selected peptide fragment, or panel of selected peptide fragments, in the sample relative to the corresponding control level is predictive of a fetus having Trisomy 21. As used herein, “difference” refers to any statistically significant difference in the level of a selected biomarker in a test sample relative to the level of the same biomarker in a corresponding control sample. Statistical methods for determining significant differences in gene expression are well known in the art. If the level of one or more selected peptide fragments in the maternal test sample is identical to, or essentially the same as, the corresponding control level (e.g., no statistically significant difference), it is unlikely that the fetus has Trisomy 21 (i.e., a negative prediction). If the level of a peptide fragment in the maternal test sample is significantly different than the corresponding control level, as determined by an appropriate statistical test(s), it is likely that the fetus has Trisomy 21 (i.e., a positive prediction). In one embodiment, the level of the biomarker is greater (e.g., up-regulated) in the test sample relative to a corresponding control level. In another embodiment, the level of the biomarker is reduced (e.g., down-regulated) in the test sample relative to a corresponding control level. For a panel of biomarkers, selected biomarkers can be either up-regulated or down-regulated, that is, a level of expression of a selected biomarker can be increased or decreased relative to control levels.
[0069] Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Singleton et al., Dictionary of Microbiology and Molecular Biology 2nd ed., J. Wiley & Sons (New York, N.Y. 1994) provides one skilled in the art with a general guide to many of the terms used in the present application.
[0070] A detailed description of the methods utilized for discovery and validation of Trisomy 21 biomarkers is set forth in the following example.
Example 1
Identification of Differentially Expressed Biomarkers in First Trimester Maternal Serum Samples from Trisomy 21 and Normal Pregnancies Using Tandem Mass Spectrometry
Materials and Methods
Clinical Serum Samples
[0071] Maternal serum samples from Trisomy 21 and normal first trimester pregnancies were provided by the Fetal Medicine Foundation (FMF) and collected from study participants with full consent and approval. The majority of these women were found to be high risk based on the FMF risk calculation for Trisomy 21. Blood samples were collected into red top tubes (BD Vacutainer™ REF 367694 Z) which do not contain anti-coagulant. The average sample volume was 7.0 ml. Tubes were labeled and kept at 4° C. less than 8 hr prior to centrifuging. Samples were centrifuged at 1,500 rpm for 15 minutes at 4° C. At the end of the spin, the tubes were taken out carefully and placed on a rack. The separated sera were gently aspirated with a pipette, transferred to microfuge tubes and frozen. Samples were transported frozen and thawed immediately before processing. Samples from Trisomy 21 patients and healthy control patients were processed in a random order to prevent systematic errors and variations from experiment to experiment.
Sample Processing
Cibachron Blue Enrichment of Serum Samples
[0072] Serum samples (20 μl) were processed using ProXPRESSION™ biomarker enrichment kits (PerkinElmer) as described in Lopez M. F., et al. Clinical Chemistry 53: 1067-1074, (2007), the teachings of which are incorporated herein by reference. The final elution step was modified from the published protocol as 8M Guanidine HCL, pH 8.5 was substituted for the kit elution buffer. The Cibachron Blue dye affinity chromatography-based technology is designed to enrich the peptide and protein fragments bound to carrier proteins (such as albumin) in plasma and serum samples. After elution from the Cibachron Blue resin [PerkinElmer, Waltham, Mass.], samples were reduced and alkylated. For this procedure, 10 mM Dithiothreitol (DTT) was added and the samples were incubated at 37° C. for 1 h. The denatured samples were then alkylated with 45 mM iodoacetic acid (500 mM stock concentration in 1 M ammonium bicarbonate) in the dark for 1 h at room temperature. Residual alkylation agent was then reacted with 15 mM DTT followed by addition of trifluoroacetic acid (TFA) to a final concentration of 2% (V/V) to acidify the sample. Following reduction/alkylation, samples were desalted with HyperSep™-96 C18 solid phase extraction media (Thermo-Fisher Scientific). Briefly, the HyperSep™ C18 resin was conditioned before use with n-Propanol. Samples were then loaded on the resin and washed with 8M Guanidine HCl, 10 mM Dithiothreitol (DTT), 150 mM Tris HCL pH 8.5 diluted 4:1 with TFA to a final concentration of 0.25% (V/V) and eluted with 50% (V/V) n-Propanol in 0.1% (V/V) Formic acid.
1-D SDS PAGE of Enriched Samples
[0073] After desalting, samples were loaded on SDS PAGE minigels (Invitrogen) and electrophoresed according to manufacturer's instructions. After staining with Coomassie Blue (Pierce Safe Gel Stain, Thermo Fisher Scientific), the region between MW 6 kDa and 26 kDa in each sample lane was excised and subjected to proteolysis with trypsin. The extracted peptides were subsequently analyzed by LC-MS/MS.
High Resolution LC-MS/MS
[0074] High resolution LC-MS/MS analysis was carried out on an LTQ-Orbitrap XL mass spectrometer (ThermoFisher Scientific). Samples in 5% (v/v) acetonitrile 0.1% (v/v) formic acid were injected onto a 75 μm×25 cm fused silica capillary column packed with Hypersil Gold C18AQ 5 μm media (Thermo Fisher Scientific), in a 250 μL/min gradient of 5% (v/v) acetonitrile, 0.1% (v/v) formic acid to 30% (v/v) acetonitrile, 0.1% (v/v) formic acid over the course of 180 minutes with a total run length of 240 minutes. The LTQ-Orbitrap was run in a top 5 configuration at 60K resolution for a full scan, with monoisotopic precursor selection enabled, and +1, and unassigned charge state rejected. The analysis was carried out with CID and HCD fragmentation modes. Label-free, differential analysis and protein identification were performed using the SIEVE (Thermo Fisher Scientific) algorithm and SEQUEST® (Sutton J et al., Proteomics Clin. Appl. 2008, 2, 862-881).
Selective Reaction Monitoring (SRM) Assays
[0075] SRM assays were developed in a Quantum Ultra or Vantage triple quadrupole mass spectrometer, Surveyor MS pump, Micro Autosampler and an IonMax Source equipped with a low flow metal needle (ThermoFisher Scientific). Reverse phase separations were carried out on a 1 mm×50 mm Hypersil Gold 1.9 μm C18 particle (ThermoFisher Scientific). Solvent A was LC-MS grade water with 0.2% (v/v) formic acid, and solvent B was LC-MS grade 30% (v/v) acetonitrile with 0.2% (v/v) formic acid (Optima grade reagents, ThermoFisher Scientific). SRM workflow prototype software (available upon request from ThermoFisher Scientific) was used for targeted protein quantitation. This software algorithm can be used for predicting candidate peptides and choosing multiple fragment ions for SRM assay design, building an instrument method and a sequence file, and also for automatic peptide identity confirmation and quantitative data processing. A workflow diagram for this process is depicted in FIG. 2. Specifically, differentially expressed peptides that were identified in the LC-MS/MS discovery MS data were imported directly into SRM builder software. Transitions were chosen based on the predominant fragments observed in the discovery data (>5 transitions per peptide). Peptides were identified by the co-eluting light and AQUA-labeled heavy transitions. Moreover, the ratio of the transitions for confirmed with the discovery spectra for additional verification. Finally, time alignment and relative quantification of the transitions was performed with SRM builder.
Results
[0076] Using the techniques described above, approximately 2400 peptide fragments representing 19 target proteins were identified as being differentially expressed in first trimester maternal serum samples from Trisomy 21 pregnancies relative to normal pregnancies. The amino acid sequences, m/z transitions and parent target protein for each of the identified peptides is shown in Table 1. A workflow diagram for the entire process, including sample enrichment and subsequent analysis, is shown in FIG. 1.
[0000] [00001] Parent Peptide SEQ Ion Fragment Accession ID Mass/ Ion Mass/ Protein Name Number Peptide Fragment NO: Charge Charge apolipoprotein B precursor NP_000375.2 SQAIATK 1 359.7083 319.1971 apolipoprotein B precursor NP_000375.2 SQAIATK 1 359.7083 432.2811 apolipoprotein B precursor NP_000375.2 SQAIATK 1 359.7083 503.3182 apolipoprotein B precursor NP_000375.2 SQAIATK 1 359.7083 631.3768 pregnancy-zone protein NP_002855.1 GVPIPNK 2 362.7213 358.2079 pregnancy-zone protein NP_002855.1 GVPIPNK 2 362.7213 471.292 pregnancy-zone protein NP_002855.1 GVPIPNK 2 362.7213 568.3448 pregnancy-zone protein NP_002855.1 GVPIPNK 2 362.7213 667.4132 alpha-2-macroglobulin precursor NP_000005.2 GVPIPNK 3 362.7253 358.2079 alpha-2-macroglobulin precursor NP_000005.2 GVPIPNK 3 362.7253 471.292 alpha-2-macroglobulin precursor NP_000005.2 GVPIPNK 3 362.7253 568.3448 alpha-2-macroglobulin precursor NP_000005.2 GVPIPNK 3 362.7253 667.4132 apolipoprotein B precursor NP_000375.2 INSGAHK 4 363.6983 355.2083 apolipoprotein B precursor NP_000375.2 INSGAHK 4 363.6983 412.2297 apolipoprotein B precursor NP_000375.2 INSGAHK 4 363.6983 499.2618 apolipoprotein B precursor NP_000375.2 INSGAHK 4 363.6983 613.3047 apolipoprotein B precursor NP_000375.2 LAIPEGK 5 364.2211 333.1763 apolipoprotein B precursor NP_000375.2 LAIPEGK 5 364.2211 430.2291 apolipoprotein B precursor NP_000375.2 LAIPEGK 5 364.2211 543.3131 apolipoprotein B precursor NP_000375.2 LAIPEGK 5 364.2211 614.3503 apolipoprotein B precursor NP_000375.2 VSQEGLK 6 380.7136 317.2178 apolipoprotein B precursor NP_000375.2 VSQEGLK 6 380.7136 446.2604 apolipoprotein B precursor NP_000375.2 VSQEGLK 6 380.7136 574.319 apolipoprotein B precursor NP_000375.2 VSQEGLK 6 380.7136 661.351 apolipoprotein C-I precursor NP_001636.1 QSELSAK 7 381.7032 305.1814 apolipoprotein C-I precursor NP_001636.1 QSELSAK 7 381.7032 418.2655 apolipoprotein C-I precursor NP_001636.1 QSELSAK 7 381.7032 547.308 apolipoprotein C-I precursor NP_001636.1 QSELSAK 7 381.7032 634.3401 apolipoprotein B precursor NP_000375.2 NFATSNK 8 391.1956 348.1872 apolipoprotein B precursor NP_000375.2 NFATSNK 8 391.1956 449.2349 apolipoprotein B precursor NP_000375.2 NFATSNK 8 391.1956 520.272 apolipoprotein B precursor NP_000375.2 NFATSNK 8 391.1956 667.3404 apolipoprotein E precursor NP_000032.1 DADDLQK 9 402.6903 388.2549 apolipoprotein E precursor NP_000032.1 DADDLQK 9 402.6903 503.2818 apolipoprotein E precursor NP_000032.1 DADDLQK 9 402.6903 618.3088 apolipoprotein E precursor NP_000032.1 DADDLQK 9 402.6903 689.3459 serum amyloid P component precursor NP_001630.1 AYSDLSR 10 406.2009 375.2345 serum amyloid P component precursor NP_001630.1 AYSDLSR 10 406.2009 490.2614 serum amyloid P component precursor NP_001630.1 AYSDLSR 10 406.2009 577.2935 serum amyloid P component precursor NP_001630.1 AYSDLSR 10 406.2009 740.3568 ceruloplasmin precursor NP_000087.1 GSLHANGR 11 406.2121 346.1828 ceruloplasmin precursor NP_000087.1 GSLHANGR 11 406.2121 417.2199 ceruloplasmin precursor NP_000087.1 GSLHANGR 11 406.2121 554.2788 ceruloplasmin precursor NP_000087.1 GSLHANGR 11 406.2121 667.3629 ceruloplasmin precursor NP_000087.1 GSLHANGR 11 406.2121 754.3949 apolipoprotein E precursor NP_000032.1 AQAWGER 12 409.2012 361.1825 apolipoprotein E precursor NP_000032.1 AQAWGER 12 409.2012 547.2618 apolipoprotein E precursor NP_000032.1 AQAWGER 12 409.2012 618.2989 apolipoprotein E precursor NP_000032.1 AQAWGER 12 409.2012 746.3575 alpha-2-macroglobulin precursor NP_000005.2 QSSEITR 13 410.7116 389.2502 alpha-2-macroglobulin precursor NP_000005.2 QSSEITR 13 410.7116 518.2927 alpha-2-macroglobulin precursor NP_000005.2 QSSEITR 13 410.7116 605.3248 alpha-2-macroglobulin precursor NP_000005.2 QSSEITR 13 410.7116 692.3568 apolipoprotein E precursor NP_000032.1 EQVAEVR 14 415.722 403.2294 apolipoprotein E precursor NP_000032.1 EQVAEVR 14 415.722 474.2665 apolipoprotein E precursor NP_000032.1 EQVAEVR 14 415.722 573.335 apolipoprotein E precursor NP_000032.1 EQVAEVR 14 415.722 701.3935 apolipoprotein A-IV precursor NP_000473.2 GNTEGLQK 15 423.7194 388.2549 apolipoprotein A-IV precursor NP_000473.2 GNTEGLQK 15 423.7194 445.2764 apolipoprotein A-IV precursor NP_000473.2 GNTEGLQK 15 423.7194 574.319 apolipoprotein A-IV precursor NP_000473.2 GNTEGLQK 15 423.7194 675.3666 apolipoprotein A-IV precursor NP_000473.2 GNTEGLQK 15 423.7194 789.4095 apolipoprotein E precursor NP_000032.1 ELQAAQAR 16 443.7407 374.2141 apolipoprotein E precursor NP_000032.1 ELQAAQAR 16 443.7407 445.2512 apolipoprotein E precursor NP_000032.1 ELQAAQAR 16 443.7407 516.2883 apolipoprotein E precursor NP_000032.1 ELQAAQAR 16 443.7407 644.3469 apolipoprotein E precursor NP_000032.1 ELQAAQAR 16 443.7407 757.431 apolipoprotein B precursor NP_000375.2 HDAHLNGK 17 446.2252 318.1766 apolipoprotein B precursor NP_000375.2 HDAHLNGK 17 446.2252 431.2607 apolipoprotein B precursor NP_000375.2 HDAHLNGK 17 446.2252 568.3196 apolipoprotein B precursor NP_000375.2 HDAHLNGK 17 446.2252 639.3568 apolipoprotein B precursor NP_000375.2 HDAHLNGK 17 446.2252 754.3837 serum amyloid A4; constitutive NP_006503.1 GNYDAAQR 18 447.7068 374.2141 serum amyloid A4; constitutive NP_006503.1 GNYDAAQR 18 447.7068 445.2512 serum amyloid A4; constitutive NP_006503.1 GNYDAAQR 18 447.7068 560.2781 serum amyloid A4; constitutive NP_006503.1 GNYDAAQR 18 447.7068 723.3415 serum amyloid A4; constitutive NP_006503.1 GNYDAAQR 18 447.7068 837.3844 apolipoprotein B precursor NP_000375.2 LNGESNLR 19 451.7382 402.2454 apolipoprotein B precursor NP_000375.2 LNGESNLR 19 451.7382 489.2774 apolipoprotein B precursor NP_000375.2 LNGESNLR 19 451.7382 618.32 apolipoprotein B precursor NP_000375.2 LNGESNLR 19 451.7382 675.3415 apolipoprotein B precursor NP_000375.2 LNGESNLR 19 451.7382 789.3844 apolipoprotein B precursor NP_000375.2 QELNGNTK 20 452.2302 362.2029 apolipoprotein B precursor NP_000375.2 QELNGNTK 20 452.2302 419.2243 apolipoprotein B precursor NP_000375.2 QELNGNTK 20 452.2302 533.2673 apolipoprotein B precursor NP_000375.2 QELNGNTK 20 452.2302 646.3513 apolipoprotein B precursor NP_000375.2 QELNGNTK 20 452.2302 775.3939 paraoxonase 1 NP_000437.3 SFNPNSPGK 21 474.2327 301.1865 paraoxonase 1 NP_000437.3 SFNPNSPGK 21 474.2327 388.2185 paraoxonase 1 NP_000437.3 SFNPNSPGK 21 474.2327 502.2614 paraoxonase 1 NP_000437.3 SFNPNSPGK 21 474.2327 599.3142 paraoxonase 1 NP_000437.3 SFNPNSPGK 21 474.2327 713.3571 paraoxonase 1 NP_000437.3 SFNPNSPGK 21 474.2327 860.4255 apolipoprotein A-IV precursor NP_000473.2 QLTPYAQR 22 488.7642 374.2141 apolipoprotein A-IV precursor NP_000473.2 QLTPYAQR 22 488.7642 537.2774 apolipoprotein A-IV precursor NP_000473.2 QLTPYAQR 22 488.7642 634.3302 apolipoprotein A-IV precursor NP_000473.2 QLTPYAQR 22 488.7642 735.3779 apolipoprotein A-IV precursor NP_000473.2 QLTPYAQR 22 488.7642 848.4619 apolipoprotein B precursor NP_000375.2 VNDESTEGK 23 489.7224 333.1763 apolipoprotein B precursor NP_000375.2 VNDESTEGK 23 489.7224 434.224 apolipoprotein B precursor NP_000375.2 VNDESTEGK 23 489.7224 521.256 apolipoprotein B precursor NP_000375.2 VNDESTEGK 23 489.7224 650.2986 apolipoprotein B precursor NP_000375.2 VNDESTEGK 23 489.7224 765.3256 apolipoprotein B precursor NP_000375.2 VNDESTEGK 23 489.7224 879.3685 apolipoprotein H precursor NP_000033.1 TDASDVKPC[Carboxymethyl] 24 497.2133 405.1797 apolipoprotein H precursor NP_000033.1 TDASDVKPC[Carboxymethyl] 24 497.2133 504.2481 apolipoprotein H precursor NP_000033.1 TDASDVKPC[Carboxymethyl] 24 497.2133 619.275 apolipoprotein H precursor NP_000033.1 TDASDVKPC[Carboxymethyl] 24 497.2133 706.3071 apolipoprotein H precursor NP_000033.1 TDASDVKPC[Carboxymethyl] 24 497.2133 777.3442 apolipoprotein H precursor NP_000033.1 TDASDVKPC[Carboxymethyl] 24 497.2133 892.3711 apolipoprotein C-I precursor NP_001636.1 IKQSELSAK 25 502.2928 305.1814 apolipoprotein C-I precursor NP_001636.1 IKQSELSAK 25 502.2928 418.2655 apolipoprotein C-I precursor NP_001636.1 IKQSELSAK 25 502.2928 547.308 apolipoprotein C-I precursor NP_001636.1 IKQSELSAK 25 502.2928 634.3401 apolipoprotein C-I precursor NP_001636.1 IKQSELSAK 25 502.2928 762.3987 apolipoprotein C-I precursor NP_001636.1 IKQSELSAK 25 502.2928 890.4937 apolipoprotein B precursor NP_000375.2 GAYQNNEIK 26 518.7565 389.2389 apolipoprotein B precursor NP_000375.2 GAYQNNEIK 26 518.7565 503.2818 apolipoprotein B precursor NP_000375.2 GAYQNNEIK 26 518.7565 617.3248 apolipoprotein B precursor NP_000375.2 GAYQNNEIK 26 518.7565 745.3834 apolipoprotein B precursor NP_000375.2 GAYQNNEIK 26 518.7565 908.4467 apolipoprotein B precursor NP_000375.2 GAYQNNEIK 26 518.7565 979.4838 apolipoprotein B precursor NP_000375.2 ESDEETQIK 27 539.7486 388.2549 apolipoprotein B precursor NP_000375.2 ESDEETQIK 27 539.7486 489.3026 apolipoprotein B precursor NP_000375.2 ESDEETQIK 27 539.7486 618.3452 apolipoprotein B precursor NP_000375.2 ESDEETQIK 27 539.7486 747.3878 apolipoprotein B precursor NP_000375.2 ESDEETQIK 27 539.7486 862.4147 apolipoprotein B precursor NP_000375.2 ESDEETQIK 27 539.7486 949.4467 histidine-rich glycoprotein precursor NP_000403.1 HSHESQDLR 28 554.7601 403.2294 histidine-rich glycoprotein precursor NP_000403.1 HSHESQDLR 28 554.7601 531.288 histidine-rich glycoprotein precursor NP_000403.1 HSHESQDLR 28 554.7601 618.32 histidine-rich glycoprotein precursor NP_000403.1 HSHESQDLR 28 554.7601 747.3626 histidine-rich glycoprotein precursor NP_000403.1 HSHESQDLR 28 554.7601 884.4215 histidine-rich glycoprotein precursor NP_000403.1 HSHESQDLR 28 554.7601 971.4536 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 347.192 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 418.2291 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 546.2877 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 659.3717 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 788.4143 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 885.4671 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 972.4991 apolipoprotein A-II preproprotein NP_001634.1 VKSPELQAEAK 29 600.3351 1100.594 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 411.2233 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 510.2917 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 647.3506 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 734.3826 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 791.4041 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 928.463 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 1029.511 pregnancy-zone protein NP_002855.1 EGTHGSHVYTK 30 608.2913 1086.532 ceruloplasmin precursor NP_000087.1 EDEDFQESNK 31 620.7518 348.1872 ceruloplasmin precursor NP_000087.1 EDEDFQESNK 31 620.7518 477.2298 ceruloplasmin precursor NP_000087.1 EDEDFQESNK 31 620.7518 605.2884 ceruloplasmin precursor NP_000087.1 EDEDFQESNK 31 620.7518 752.3568 ceruloplasmin precursor NP_000087.1 EDEDFQESNK 31 620.7518 867.3837 ceruloplasmin precursor NP_000087.1 EDEDFQESNK 31 620.7518 996.4263 ceruloplasmin precursor NP_000087.1 EDEDFQESNK 31 620.7518 1111.453 apolipoprotein E precursor NP_000032.1 QQTEWQSGQR 32 624.2918 360.1985 apolipoprotein E precursor NP_000032.1 QQTEWQSGQR 32 624.2918 447.2305 apolipoprotein E precursor NP_000032.1 QQTEWQSGQR 32 624.2918 575.2891 apolipoprotein E precursor NP_000032.1 QQTEWQSGQR 32 624.2918 761.3683 apolipoprotein E precursor NP_000032.1 QQTEWQSGQR 32 624.2918 890.4109 apolipoprotein E precursor NP_000032.1 QQTEWQSGQR 32 624.2918 991.4586 apolipoprotein E precursor NP_000032.1 QQTEWQSGQR 32 624.2918 1119.517 ceruloplasmin precursor NP_000087.1 DNEDFQESNR 33 627.2551 376.1934 ceruloplasmin precursor NP_000087.1 DNEDFQESNR 33 627.2551 505.236 ceruloplasmin precursor NP_000087.1 DNEDFQESNR 33 627.2551 633.2946 ceruloplasmin precursor NP_000087.1 DNEDFQESNR 33 627.2551 780.3629 ceruloplasmin precursor NP_000087.1 DNEDFQESNR 33 627.2551 895.3899 ceruloplasmin precursor NP_000087.1 DNEDFQESNR 33 627.2551 1024.432 ceruloplasmin precursor NP_000087.1 DNEDFQESNR 33 627.2551 1138.475 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 361.1825 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 508.2509 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 609.2985 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 696.3306 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 859.3939 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 946.426 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 1003.447 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 1118.474 pregnancy-zone protein NP_002855.1 HQDGSYSTFGER 34 692.2998 1246.533 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 385.1461 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 472.1781 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 569.2309 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 668.2993 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 765.3521 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 836.3892 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 907.4263 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 994.4583 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 1095.506 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 1152.527 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 1251.596 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 1322.633 apolipoprotein E precursor NP_000032.1 VQAAVGTSAAPVPSDNH 35 810.9025 1393.67 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 381.2239 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 518.2828 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 631.3669 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 746.3939 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 833.4259 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 920.4579 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 1034.501 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 1148.544 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 1262.587 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 1399.646 histidine-rich glycoprotein precursor NP_000403.1 HSHNNNSSDLHPHK 36 812.3722 1486.678 apolipoprotein A-II preproprotein NP_001634.1 SPELQAEAK 37 486.7534 347.192 apolipoprotein A-II preproprotein NP_001634.1 SPELQAEAK 37 486.7534 418.2291 apolipoprotein A-II preproprotein NP_001634.1 SPELQAEAK 37 486.7534 546.2877 apolipoprotein A-II preproprotein NP_001634.1 SPELQAEAK 37 486.7534 659.3717 apolipoprotein A-II preproprotein NP_001634.1 SPELQAEAK 37 486.7534 788.4143 apolipoprotein A-II preproprotein NP_001634.1 SPELQAEAK 37 486.7534 885.4671 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 404.2134 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 505.2611 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 620.288 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 748.3466 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 819.3837 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 982.4471 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 1079.5 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 1150.537 apolipoprotein A-IV precursor NP_000473.2 SLAPYAQDTQEK 38 675.8304 1263.621 ceruloplasmin precursor NP_000087.1 QYTDSTFR 39 509.2354 423.2345 ceruloplasmin precursor NP_000087.1 QYTDSTFR 39 509.2354 510.2665 ceruloplasmin precursor NP_000087.1 QYTDSTFR 39 509.2354 625.2935 ceruloplasmin precursor NP_000087.1 QYTDSTFR 39 509.2354 726.3411 ceruloplasmin precursor NP_000087.1 QYTDSTFR 39 509.2354 889.4045 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 377.1774 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 448.2145 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 549.2621 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 606.2836 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 703.3364 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 802.4048 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 859.4263 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 946.4583 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 1033.49 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 1120.522 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 1249.565 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 1320.602 apolipoprotein B precursor NP_000375.2 YTYNYEAESSSGVPGTADSR 40 1077.467 1449.645 apolipoprotein B precursor NP_000375.2 ETLEDTR 41 432.2089 391.193 apolipoprotein B precursor NP_000375.2 ETLEDTR 41 432.2089 520.2356 apolipoprotein B precursor NP_000375.2 ETLEDTR 41 432.2089 633.3197 apolipoprotein B precursor NP_000375.2 ETLEDTR 41 432.2089 734.3674 histidine-rich glycoprotein precursor NP_000403.1 QIGSVYR 42 411.7271 437.2502 histidine-rich glycoprotein precursor NP_000403.1 QIGSVYR 42 411.7271 524.2822 histidine-rich glycoprotein precursor NP_000403.1 QIGSVYR 42 411.7271 581.3036 histidine-rich glycoprotein precursor NP_000403.1 QIGSVYR 42 411.7271 694.3877 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 462.2342 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 590.2927 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 753.3561 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 854.4037 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 911.4252 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 1012.473 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 1113.521 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 1170.542 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 1257.574 apolipoprotein B precursor NP_000375.2 AASGTTGTYQEWK 43 700.3281 1328.611 histidine-rich glycoprotein precursor NP_000403.1 IADAHLDR 44 455.7407 403.2294 histidine-rich glycoprotein precursor NP_000403.1 IADAHLDR 44 455.7407 540.2883 histidine-rich glycoprotein precursor NP_000403.1 IADAHLDR 44 455.7407 611.3254 histidine-rich glycoprotein precursor NP_000403.1 IADAHLDR 44 455.7407 726.3524 histidine-rich glycoprotein precursor NP_000403.1 IADAHLDR 44 455.7407 797.3895 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669 361.1825 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669 489.241 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669 751.3728 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669 850.4412 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669 951.4889 apolipoprotein A-I preproprotein NP_000030.1 AHVDALR 46 391.2194 359.2396 apolipoprotein A-I preproprotein NP_000030.1 AHVDALR 46 391.2194 474.2665 apolipoprotein A-I preproprotein NP_000030.1 AHVDALR 46 391.2194 573.335 apolipoprotein A-I preproprotein NP_000030.1 AHVDALR 46 391.2194 710.3939 pregnancy-zone protein NP_002855.1 LPSNVVK 47 378.7343 345.2491 pregnancy-zone protein NP_002855.1 LPSNVVK 47 378.7343 459.292 pregnancy-zone protein NP_002855.1 LPSNVVK 47 378.7343 546.324 pregnancy-zone protein NP_002855.1 LPSNVVK 47 378.7343 643.3768 apolipoprotein B precursor NP_000375.2 FFGEGTK 48 393.1951 305.1814 apolipoprotein B precursor NP_000375.2 FFGEGTK 48 393.1951 434.224 apolipoprotein B precursor NP_000375.2 FFGEGTK 48 393.1951 491.2455 apolipoprotein B precursor NP_000375.2 FFGEGTK 48 393.1951 638.3138 serum amyloid A4; constitutive NP_006503.1 FRPDGLPK 49 465.2638 357.2491 serum amyloid A4; constitutive NP_006503.1 FRPDGLPK 49 465.2638 414.2705 serum amyloid A4; constitutive NP_006503.1 FRPDGLPK 49 465.2638 529.2975 serum amyloid A4; constitutive NP_006503.1 FRPDGLPK 49 465.2638 626.3503 serum amyloid A4; constitutive NP_006503.1 FRPDGLPK 49 465.2638 782.4514 apolipoprotein E precursor NP_000032.1 LEEQAQQIR 50 557.7962 416.261 apolipoprotein E precursor NP_000032.1 LEEQAQQIR 50 557.7962 544.3196 apolipoprotein E precursor NP_000032.1 LEEQAQQIR 50 557.7962 615.3568 apolipoprotein E precursor NP_000032.1 LEEQAQQIR 50 557.7962 743.4153 apolipoprotein E precursor NP_000032.1 LEEQAQQIR 50 557.7962 872.4579 apolipoprotein E precursor NP_000032.1 LEEQAQQIR 50 557.7962 1001.5 apolipoprotein B precursor NP_000375.2 QAEAVLK 51 379.724 359.2647 apolipoprotein B precursor NP_000375.2 QAEAVLK 51 379.724 430.3018 apolipoprotein B precursor NP_000375.2 QAEAVLK 51 379.724 559.3444 apolipoprotein B precursor NP_000375.2 QAEAVLK 51 379.724 630.3815 apolipoprotein B precursor NP_000375.2 YYELEEK 52 487.2293 405.1974 apolipoprotein B precursor NP_000375.2 YYELEEK 52 487.2293 518.2815 apolipoprotein B precursor NP_000375.2 YYELEEK 52 487.2293 647.3241 apolipoprotein B precursor NP_000375.2 YYELEEK 52 487.2293 810.3875 apolipoprotein E precursor NP_000032.1 LAVYQAGAR 53 474.7667 303.177 apolipoprotein E precursor NP_000032.1 LAVYQAGAR 53 474.7667 374.2141 apolipoprotein E precursor NP_000032.1 LAVYQAGAR 53 474.7667 502.2727 apolipoprotein E precursor NP_000032.1 LAVYQAGAR 53 474.7667 665.336 apolipoprotein E precursor NP_000032.1 LAVYQAGAR 53 474.7667 764.4044 apolipoprotein E precursor NP_000032.1 LAVYQAGAR 53 474.7667 835.4415 apolipoprotein A-IV precursor NP_000473.2 EAVEHLQK 54 477.2562 388.2549 apolipoprotein A-IV precursor NP_000473.2 EAVEHLQK 54 477.2562 525.3138 apolipoprotein A-IV precursor NP_000473.2 EAVEHLQK 54 477.2562 654.3564 apolipoprotein A-IV precursor NP_000473.2 EAVEHLQK 54 477.2562 753.4248 apolipoprotein A-IV precursor NP_000473.2 EAVEHLQK 54 477.2562 824.4619 apolipoprotein C-II precursor NP_000474.2 TAAQNLYEK 55 519.2667 439.2182 apolipoprotein C-II precursor NP_000474.2 TAAQNLYEK 55 519.2667 552.3022 apolipoprotein C-II precursor NP_000474.2 TAAQNLYEK 55 519.2667 666.3452 apolipoprotein C-II precursor NP_000474.2 TAAQNLYEK 55 519.2667 794.4037 apolipoprotein C-II precursor NP_000474.2 TAAQNLYEK 55 519.2667 865.4409 apolipoprotein C-II precursor NP_000474.2 TAAQNLYEK 55 519.2667 936.478 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 362.2029 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 461.2713 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 590.3138 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 704.3568 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 775.3939 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 912.4528 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 1009.506 apolipoprotein A-IV precursor NP_000473.2 LLPHANEVSQK 56 618.3408 1122.59 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 319.1607 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 448.2032 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 577.2458 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 740.3092 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 869.3517 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 940.3889 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 1027.421 apolipoprotein B precursor NP_000375.2 DFSAEYEEDGK 57 645.262 1174.489 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 416.261 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 545.3036 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 616.3408 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 744.3994 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 845.447 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 932.4791 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 1031.547 apolipoprotein A-IV precursor NP_000473.2 TQVSTQAEQLR 58 630.8307 1159.606 pregnancy-zone protein NP_002855.1 YGAATFTR 59 443.7245 423.2345 pregnancy-zone protein NP_002855.1 YGAATFTR 59 443.7245 524.2822 pregnancy-zone protein NP_002855.1 YGAATFTR 59 443.7245 595.3193 pregnancy-zone protein NP_002855.1 YGAATFTR 59 443.7245 666.3564 pregnancy-zone protein NP_002855.1 YGAATFTR 59 443.7245 723.3779 apolipoprotein D precursor NP_001638.1 IPTTFENGR 60 517.7709 346.1828 apolipoprotein D precursor NP_001638.1 IPTTFENGR 60 517.7709 475.2254 apolipoprotein D precursor NP_001638.1 IPTTFENGR 60 517.7709 622.2938 apolipoprotein D precursor NP_001638.1 IPTTFENGR 60 517.7709 723.3415 apolipoprotein D precursor NP_001638.1 IPTTFENGR 60 517.7709 824.3892 apolipoprotein D precursor NP_001638.1 IPTTFENGR 60 517.7709 921.4419 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 377.2025 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 514.2614 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 627.3455 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 714.3775 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 785.4147 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 884.483 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 985.5308 apolipoprotein B precursor NP_000375.2 SNTVASLHTEK 61 593.8068 1099.574 apolipoprotein A-IV precursor NP_000473.2 VEPYGENFNK 62 598.7828 408.2236 apolipoprotein A-IV precursor NP_000473.2 VEPYGENFNK 62 598.7828 522.2665 apolipoprotein A-IV precursor NP_000473.2 VEPYGENFNK 62 598.7828 651.3091 apolipoprotein A-IV precursor NP_000473.2 VEPYGENFNK 62 598.7828 708.3306 apolipoprotein A-IV precursor NP_000473.2 VEPYGENFNK 62 598.7828 871.3939 apolipoprotein A-IV precursor NP_000473.2 VEPYGENFNK 62 598.7828 968.4467 apolipoprotein A-IV precursor NP_000473.2 VEPYGENFNK 62 598.7828 1097.489 apolipoprotein C-II precursor NP_000474.2 LRDLYSK 63 447.7558 397.2076 apolipoprotein C-II precursor NP_000474.2 LRDLYSK 63 447.7558 510.2917 apolipoprotein C-II precursor NP_000474.2 LRDLYSK 63 447.7558 625.3186 apolipoprotein C-II precursor NP_000474.2 LRDLYSK 63 447.7558 781.4197 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 261.1552 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 424.2185 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 511.2505 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 626.2775 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 754.3361 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 883.3787 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 1011.437 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 1068.459 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 1181.543 serum amyloid P component precursor NP_001630.1 IVLGQEQDSYGGK 64 697.3515 1280.611 apolipoprotein B precursor NP_000375.2 LDNIYSSDK 65 527.7562 349.1712 apolipoprotein B precursor NP_000375.2 LDNIYSSDK 65 527.7562 436.2032 apolipoprotein B precursor NP_000375.2 LDNIYSSDK 65 527.7562 599.2666 apolipoprotein B precursor NP_000375.2 LDNIYSSDK 65 527.7562 712.3506 apolipoprotein B precursor NP_000375.2 LDNIYSSDK 65 527.7562 826.3936 apolipoprotein B precursor NP_000375.2 LDNIYSSDK 65 527.7562 941.4205 apolipoprotein B precursor NP_000375.2 VAWHYDEEK 66 588.7697 405.1974 apolipoprotein B precursor NP_000375.2 VAWHYDEEK 66 588.7697 520.2244 apolipoprotein B precursor NP_000375.2 VAWHYDEEK 66 588.7697 683.2877 apolipoprotein B precursor NP_000375.2 VAWHYDEEK 66 588.7697 820.3466 apolipoprotein B precursor NP_000375.2 VAWHYDEEK 66 588.7697 1006.426 apolipoprotein B precursor NP_000375.2 VAWHYDEEK 66 588.7697 1077.463 apolipoprotein B precursor NP_000375.2 VSSFYAK 67 401.2107 381.2127 apolipoprotein B precursor NP_000375.2 VSSFYAK 67 401.2107 528.2811 apolipoprotein B precursor NP_000375.2 VSSFYAK 67 401.2107 615.3131 apolipoprotein B precursor NP_000375.2 VSSFYAK 67 401.2107 702.3452 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 333.1875 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 462.2301 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 591.2727 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 690.3411 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 789.4095 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 903.4525 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 1000.505 alpha-2-macroglobulin precursor NP_000005.2 LPPNVVEESAR 68 605.825 1097.558 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 348.1872 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 477.2298 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 590.3138 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 737.3823 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 866.4249 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 995.4675 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 1110.494 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 1225.521 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 1353.616 ceruloplasmin precursor NP_000087.1 VNKDDEEFIESNK 69 783.8677 1467.659 apolipoprotein B precursor NP_000375.2 EAQEVFK 70 425.7189 393.2491 apolipoprotein B precursor NP_000375.2 EAQEVFK 70 425.7189 522.2917 apolipoprotein B precursor NP_000375.2 EAQEVFK 70 425.7189 650.3503 apolipoprotein B precursor NP_000375.2 EAQEVFK 70 425.7189 721.3874 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 417.2451 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 488.2822 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 617.3248 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 688.3619 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 745.3834 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 908.4467 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 1037.489 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 1094.511 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 1165.548 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 1302.607 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 1373.644 alpha 1 globin NP_000549.1 VGAHAGEYGAEALER 71 765.3708 1430.665 apolipoprotein E precursor NP_000032.1 LQAEAFQAR 72 517.2749 374.2141 apolipoprotein E precursor NP_000032.1 LQAEAFQAR 72 517.2749 521.2825 apolipoprotein E precursor NP_000032.1 LQAEAFQAR 72 517.2749 592.3196 apolipoprotein E precursor NP_000032.1 LQAEAFQAR 72 517.2749 721.3622 apolipoprotein E precursor NP_000032.1 LQAEAFQAR 72 517.2749 792.3994 apolipoprotein E precursor NP_000032.1 LQAEAFQAR 72 517.2749 920.4579 apolipoprotein D precursor NP_001638.1 VLNQELR 73 436.2534 417.2451 apolipoprotein D precursor NP_001638.1 VLNQELR 73 436.2534 545.3036 apolipoprotein D precursor NP_001638.1 VLNQELR 73 436.2534 659.3466 apolipoprotein D precursor NP_001638.1 VLNQELR 73 436.2534 772.4306 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 291.1657 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 378.1978 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 479.2455 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 665.3248 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 736.3619 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 849.4459 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 986.5049 apolipoprotein B precursor NP_000375.2 AGHIAWTSSGK 74 557.7856 1043.526 apolipoprotein B precursor NP_000375.2 AAIQALR 75 371.7321 359.2396 apolipoprotein B precursor NP_000375.2 AAIQALR 75 371.7321 487.2982 apolipoprotein B precursor NP_000375.2 AAIQALR 75 371.7321 600.3822 apolipoprotein B precursor NP_000375.2 AAIQALR 75 371.7321 671.4193 alpha 1 globin NP_000549.1 VDPVNFK 76 409.724 408.2236 alpha 1 globin NP_000549.1 VDPVNFK 76 409.724 507.292 alpha 1 globin NP_000549.1 VDPVNFK 76 409.724 604.3448 alpha 1 globin NP_000549.1 VDPVNFK 76 409.724 719.3717 serum amyloid A4; constitutive NP_006503.1 GPGGVWAAK 77 421.7296 289.1865 serum amyloid A4; constitutive NP_006503.1 GPGGVWAAK 77 421.7296 475.2658 serum amyloid A4; constitutive NP_006503.1 GPGGVWAAK 77 421.7296 574.3342 serum amyloid A4; constitutive NP_006503.1 GPGGVWAAK 77 421.7296 631.3557 serum amyloid A4; constitutive NP_006503.1 GPGGVWAAK 77 421.7296 688.3771 serum amyloid A4; constitutive NP_006503.1 GPGGVWAAK 77 421.7296 785.4299 apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 360.2236 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 475.2505 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 622.319 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 736.3619 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 865.4045 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 993.4631 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 1092.531 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 1189.584 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 1286.637 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 1400.68 NK apolipoprotein D precursor NP_001638.1 C[Carboxymethyl]PNPPVQENFDV 78 829.8776 1497.733 NK apolipoprotein B precursor NP_000375.2 QIDDIDVR 79 487.2511 389.2137 apolipoprotein B precursor NP_000375.2 QIDDIDVR 79 487.2511 502.2978 apolipoprotein B precursor NP_000375.2 QIDDIDVR 79 487.2511 617.3248 apolipoprotein B precursor NP_000375.2 QIDDIDVR 79 487.2511 732.3517 apolipoprotein B precursor NP_000375.2 QIDDIDVR 79 487.2511 845.4358 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 436.1855 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 493.207 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 606.291 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 705.3594 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 818.4435 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 947.4861 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 1034.518 histidine-rich glycoprotein precursor NP_000403.1 RPSEIVIGQC[Carboxymethyl]K 80 644.3399 1131.571 apolipoprotein A-IV precursor NP_000473.2 IDQNVEELK 81 544.2852 389.2389 apolipoprotein A-IV precursor NP_000473.2 IDQNVEELK 81 544.2852 518.2815 apolipoprotein A-IV precursor NP_000473.2 IDQNVEELK 81 544.2852 617.3499 apolipoprotein A-IV precursor NP_000473.2 IDQNVEELK 81 544.2852 731.3928 apolipoprotein A-IV precursor NP_000473.2 IDQNVEELK 81 544.2852 859.4514 apolipoprotein A-IV precursor NP_000473.2 IDQNVEELK 81 544.2852 974.4784 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 363.1869 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 476.2709 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 577.3186 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 664.3506 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 777.4347 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 914.4937 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 1043.536 apolipoprotein A-I preproprotein NP_000030.1 ATEHLSTLSEK 82 608.3144 1144.584 pregnancy-zone protein NP_002855.1 YNILPEK 83 438.7449 373.2076 pregnancy-zone protein NP_002855.1 YNILPEK 83 438.7449 486.2917 pregnancy-zone protein NP_002855.1 YNILPEK 83 438.7449 599.3757 pregnancy-zone protein NP_002855.1 YNILPEK 83 438.7449 713.4186 alpha-2-macroglobulin precursor NP_000005.2 YNILPEK 84 438.7469 373.2076 alpha-2-macroglobulin precursor NP_000005.2 YNILPEK 84 438.7469 486.2917 alpha-2-macroglobulin precursor NP_000005.2 YNILPEK 84 438.7469 599.3757 alpha-2-macroglobulin precursor NP_000005.2 YNILPEK 84 438.7469 713.4186 apolipoprotein B precursor NP_000375.2 SLDEHYHIR 85 585.2885 425.2614 apolipoprotein B precursor NP_000375.2 SLDEHYHIR 85 585.2885 588.3247 apolipoprotein B precursor NP_000375.2 SLDEHYHIR 85 585.2885 725.3836 apolipoprotein B precursor NP_000375.2 SLDEHYHIR 85 585.2885 854.4262 apolipoprotein B precursor NP_000375.2 SLDEHYHIR 85 585.2885 969.4531 apolipoprotein B precursor NP_000375.2 SLDEHYHIR 85 585.2885 1082.537 beta globin NP_000509.1 LHVDPENFR 86 563.7856 436.2297 beta globin NP_000509.1 LHVDPENFR 86 563.7856 565.2723 beta globin NP_000509.1 LHVDPENFR 86 563.7856 662.3251 beta globin NP_000509.1 LHVDPENFR 86 563.7856 777.3521 beta globin NP_000509.1 LHVDPENFR 86 563.7856 876.4205 beta globin NP_000509.1 LHVDPENFR 86 563.7856 1013.479 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 360.1985 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 461.2461 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 560.3145 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 689.3571 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 802.4412 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 917.4681 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 1018.516 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 1075.537 pregnancy-zone protein NP_002855.1 EEGTDLEVTANR 87 667.3151 1204.58 apolipoprotein E precursor NP_000032.1 LGPLVEQGR 88 484.7798 360.1985 apolipoprotein E precursor NP_000032.1 LGPLVEQGR 88 484.7798 489.241 apolipoprotein E precursor NP_000032.1 LGPLVEQGR 88 484.7798 588.3094 apolipoprotein E precursor NP_000032.1 LGPLVEQGR 88 484.7798 701.3935 apolipoprotein E precursor NP_000032.1 LGPLVEQGR 88 484.7798 798.4463 apolipoprotein E precursor NP_000032.1 LGPLVEQGR 88 484.7798 855.4677 serum amyloid P component precursor NP_001630.1 QGYFVEAQPK 89 583.7957 372.2236 serum amyloid P component precursor NP_001630.1 QGYFVEAQPK 89 583.7957 443.2607 serum amyloid P component precursor NP_001630.1 QGYFVEAQPK 89 583.7957 572.3033 serum amyloid P component precursor NP_001630.1 QGYFVEAQPK 89 583.7957 671.3717 serum amyloid P component precursor NP_001630.1 QGYFVEAQPK 89 583.7957 818.4401 serum amyloid P component precursor NP_001630.1 QGYFVEAQPK 89 583.7957 981.5035 serum amyloid P component precursor NP_001630.1 QGYFVEAQPK 89 583.7957 1038.525 apolipoprotein C-I precursor NP_001636.1 EFGNTLEDK 90 526.7484 391.1818 apolipoprotein C-I precursor NP_001636.1 EFGNTLEDK 90 526.7484 504.2659 apolipoprotein C-I precursor NP_001636.1 EFGNTLEDK 90 526.7484 605.3135 apolipoprotein C-I precursor NP_001636.1 EFGNTLEDK 90 526.7484 719.3564 apolipoprotein C-I precursor NP_001636.1 EFGNTLEDK 90 526.7484 776.3779 apolipoprotein C-I precursor NP_001636.1 EFGNTLEDK 90 526.7484 923.4464 apolipoprotein A-I preproprotein NP_000030.1 AKPALEDLR 91 506.7929 403.2294 apolipoprotein A-I preproprotein NP_000030.1 AKPALEDLR 91 506.7929 532.272 apolipoprotein A-I preproprotein NP_000030.1 AKPALEDLR 91 506.7929 645.3561 apolipoprotein A-I preproprotein NP_000030.1 AKPALEDLR 91 506.7929 716.3932 apolipoprotein A-I preproprotein NP_000030.1 AKPALEDLR 91 506.7929 813.4459 apolipoprotein A-I preproprotein NP_000030.1 AKPALEDLR 91 506.7929 941.5409 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 374.2141 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 502.2727 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 573.3098 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 672.3782 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 800.4368 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 887.4688 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 1016.511 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 1144.57 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 1243.638 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 1330.67 apolipoprotein C-III precursor NP_000031.1 DALSSVQESQVAQQAR 92 858.9292 1417.702 apolipoprotein B precursor NP_000375.2 LDVTTSIGR 93 481.2693 345.2239 apolipoprotein B precursor NP_000375.2 LDVTTSIGR 93 481.2693 432.256 apolipoprotein B precursor NP_000375.2 LDVTTSIGR 93 481.2693 533.3036 apolipoprotein B precursor NP_000375.2 LDVTTSIGR 93 481.2693 634.3513 apolipoprotein B precursor NP_000375.2 LDVTTSIGR 93 481.2693 733.4197 apolipoprotein B precursor NP_000375.2 LDVTTSIGR 93 481.2693 848.4467 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 321.1763 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 468.2447 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 569.2924 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 626.3138 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 713.3459 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 800.3779 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 928.4365 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 1041.521 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 1142.568 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 1241.637 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 1369.695 alpha-2-macroglobulin precursor NP_000005.2 AAQVTIQSSGTFSSK 94 756.3887 1440.732 apolipoprotein B precursor NP_000375.2 VHELIER 95 448.2534 417.2451 apolipoprotein B precursor NP_000375.2 VHELIER 95 448.2534 530.3291 apolipoprotein B precursor NP_000375.2 VHELIER 95 448.2534 659.3717 apolipoprotein B precursor NP_000375.2 VHELIER 95 448.2534 796.4306 apolipoprotein B precursor NP_000375.2 FLDSNIK 96 418.7292 374.2393 apolipoprotein B precursor NP_000375.2 FLDSNIK 96 418.7292 461.2713 apolipoprotein B precursor NP_000375.2 FLDSNIK 96 418.7292 576.2982 apolipoprotein B precursor NP_000375.2 FLDSNIK 96 418.7292 689.3823 apolipoprotein B precursor NP_000375.2 GVISIPR 97 371.2345 385.2552 apolipoprotein B precursor NP_000375.2 GVISIPR 97 371.2345 472.2873 apolipoprotein B precursor NP_000375.2 GVISIPR 97 371.2345 585.3713 apolipoprotein B precursor NP_000375.2 GVISIPR 97 371.2345 684.4398 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 566.7744 363.1804 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 566.7744 478.2073 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 566.7744 535.2288 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 566.7744 691.3187 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 566.7744 819.3772 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 566.7744 932.4613 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 566.7744 1003.498 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 379.1753 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 494.2022 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 551.2237 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 650.2921 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 707.3135 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 835.3721 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 948.4562 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 98 574.7719 1019.493 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 345.2239 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 416.261 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 545.3036 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 602.3251 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 659.3466 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 758.415 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 887.4576 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 1002.484 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 1101.553 beta globin NP_000509.1 VNVDEVGGEALGR 99 657.8361 1215.596 apolipoprotein B precursor NP_000375.2 FIIPSPK 100 401.2471 331.1971 apolipoprotein B precursor NP_000375.2 FIIPSPK 100 401.2471 428.2498 apolipoprotein B precursor NP_000375.2 FIIPSPK 100 401.2471 541.3339 apolipoprotein B precursor NP_000375.2 FIIPSPK 100 401.2471 654.418 apolipoprotein C-II precursor NP_000474.2 TYLPAVDEK 101 518.2715 391.1818 apolipoprotein C-II precursor NP_000474.2 TYLPAVDEK 101 518.2715 490.2502 apolipoprotein C-II precursor NP_000474.2 TYLPAVDEK 101 518.2715 561.2873 apolipoprotein C-II precursor NP_000474.2 TYLPAVDEK 101 518.2715 658.3401 apolipoprotein C-II precursor NP_000474.2 TYLPAVDEK 101 518.2715 771.4241 apolipoprotein C-II precursor NP_000474.2 TYLPAVDEK 101 518.2715 934.4875 apolipoprotein B precursor NP_000375.2 LTISEQNIQR 102 601.3304 416.261 apolipoprotein B precursor NP_000375.2 LTISEQNIQR 102 601.3304 530.304 apolipoprotein B precursor NP_000375.2 LTISEQNIQR 102 601.3304 658.3625 apolipoprotein B precursor NP_000375.2 LTISEQNIQR 102 601.3304 787.4052 apolipoprotein B precursor NP_000375.2 LTISEQNIQR 102 601.3304 874.4372 apolipoprotein B precursor NP_000375.2 LTISEQNIQR 102 601.3304 987.5212 apolipoprotein B precursor NP_000375.2 LTISEQNIQR 102 601.3304 1088.569 apolipoprotein B precursor NP_000375.2 ALVDTLK 103 380.2342 361.244 apolipoprotein B precursor NP_000375.2 ALVDTLK 103 380.2342 476.2709 apolipoprotein B precursor NP_000375.2 ALVDTLK 103 380.2342 575.3394 apolipoprotein B precursor NP_000375.2 ALVDTLK 103 380.2342 688.4234 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 362.2029 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 449.2349 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 564.2618 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 677.3459 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 778.3936 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 891.4777 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 1019.536 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 1133.579 apolipoprotein B precursor NP_000375.2 INNQLTLDSNTK 104 680.857 1247.622 apolipoprotein A-IV precursor NP_000473.2 LEPYADQLR 105 552.7878 416.261 apolipoprotein A-IV precursor NP_000473.2 LEPYADQLR 105 552.7878 531.288 apolipoprotein A-IV precursor NP_000473.2 LEPYADQLR 105 552.7878 602.3251 apolipoprotein A-IV precursor NP_000473.2 LEPYADQLR 105 552.7878 765.3884 apolipoprotein A-IV precursor NP_000473.2 LEPYADQLR 105 552.7878 862.4412 apolipoprotein A-IV precursor NP_000473.2 LEPYADQLR 105 552.7878 991.4838 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 355.2083 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 468.2924 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 539.3295 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 653.3724 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 724.4095 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 823.4779 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 880.4994 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 951.5365 beta globin NP_000509.1 VVAGVANALAHK 106 575.3406 1050.605 ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 331.2334 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 492.2481 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 591.3165 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 688.3693 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 803.3962 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 874.4333 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 988.4763 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 1089.524 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 1186.577 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 1243.598 AK ceruloplasmin precursor NP_000087.1 EVGPTNADPVC[Carboxymethyl]L 107 736.3585 1342.667 AK apolipoprotein B precursor NP_000375.2 QHIEAIDVR 108 540.7935 389.2137 apolipoprotein B precursor NP_000375.2 QHIEAIDVR 108 540.7935 502.2978 apolipoprotein B precursor NP_000375.2 QHIEAIDVR 108 540.7935 573.335 apolipoprotein B precursor NP_000375.2 QHIEAIDVR 108 540.7935 702.3775 apolipoprotein B precursor NP_000375.2 QHIEAIDVR 108 540.7935 815.4616 apolipoprotein B precursor NP_000375.2 QHIEAIDVR 108 540.7935 952.5205 apolipoprotein C-III precursor NP_000031.1 DYWSTVK 109 449.7189 347.2283 apolipoprotein C-III precursor NP_000031.1 DYWSTVK 109 449.7189 434.2604 apolipoprotein C-III precursor NP_000031.1 DYWSTVK 109 449.7189 620.3397 apolipoprotein C-III precursor NP_000031.1 DYWSTVK 109 449.7189 783.403 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 404.2134 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 519.2404 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 633.2833 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 720.3153 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 833.3994 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 962.442 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 1061.51 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 1189.569 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 1276.601 apolipoprotein B precursor NP_000375.2 IHSGSFQSQVELSNDQEK 110 1016.982 1404.66 apolipoprotein B precursor NP_000375.2 LVELAHQYK 111 550.8086 438.2342 apolipoprotein B precursor NP_000375.2 LVELAHQYK 111 550.8086 575.2931 apolipoprotein B precursor NP_000375.2 LVELAHQYK 111 550.8086 646.3302 apolipoprotein B precursor NP_000375.2 LVELAHQYK 111 550.8086 759.4142 apolipoprotein B precursor NP_000375.2 LVELAHQYK 111 550.8086 888.4568 apolipoprotein B precursor NP_000375.2 LVELAHQYK 111 550.8086 987.5253 apolipoprotein A-IV precursor NP_000473.2 LAPLAEDVR 112 492.2797 389.2137 apolipoprotein A-IV precursor NP_000473.2 LAPLAEDVR 112 492.2797 518.2563 apolipoprotein A-IV precursor NP_000473.2 LAPLAEDVR 112 492.2797 589.2935 apolipoprotein A-IV precursor NP_000473.2 LAPLAEDVR 112 492.2797 702.3775 apolipoprotein A-IV precursor NP_000473.2 LAPLAEDVR 112 492.2797 799.4303 apolipoprotein A-IV precursor NP_000473.2 LAPLAEDVR 112 492.2797 870.4674 apolipoprotein B precursor NP_000375.2 TPALHFK 113 407.2345 431.2396 apolipoprotein B precursor NP_000375.2 TPALHFK 113 407.2345 544.3237 apolipoprotein B precursor NP_000375.2 TPALHFK 113 407.2345 615.3608 apolipoprotein B precursor NP_000375.2 TPALHFK 113 407.2345 712.4135 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 349.2076 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 462.2917 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 549.3237 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 648.3921 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 749.4398 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 836.4718 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 950.5148 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 1087.574 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 1174.606 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 1231.627 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 1360.67 apolipoprotein B precursor NP_000375.2 FVEGSHNSTVSLTTK 114 803.9072 1459.738 apolipoprotein B precursor NP_000375.2 TFIEDVNK 115 483.2505 360.2236 apolipoprotein B precursor NP_000375.2 TFIEDVNK 115 483.2505 475.2505 apolipoprotein B precursor NP_000375.2 TFIEDVNK 115 483.2505 604.2932 apolipoprotein B precursor NP_000375.2 TFIEDVNK 115 483.2505 717.3772 apolipoprotein B precursor NP_000375.2 TFIEDVNK 115 483.2505 864.4456 apolipoprotein B precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 466.2403 alpha-2-macroglobulin precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 523.2618 alpha-2-macroglobulin precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 624.3094 alpha-2-macroglobulin precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 738.3524 alpha-2-macroglobulin precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 851.4365 alpha-2-macroglobulin precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 1014.5 alpha-2-macroglobulin precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 1071.521 alpha-2-macroglobulin precursor NP_000005.2 AIGYLNTGYQR 116 628.3251 1184.605 apolipoprotein A-IV precursor NP_000473.2 LTPYADEFK 117 542.2715 423.2233 apolipoprotein A-IV precursor NP_000473.2 LTPYADEFK 117 542.2715 538.2502 apolipoprotein A-IV precursor NP_000473.2 LTPYADEFK 117 542.2715 609.2873 apolipoprotein A-IV precursor NP_000473.2 LTPYADEFK 117 542.2715 772.3506 apolipoprotein A-IV precursor NP_000473.2 LTPYADEFK 117 542.2715 869.4034 apolipoprotein A-IV precursor NP_000473.2 LTPYADEFK 117 542.2715 970.4511 paraoxonase 1 NP_000437.3 IQNILTEEPK 118 592.8297 373.2076 paraoxonase 1 NP_000437.3 IQNILTEEPK 118 592.8297 502.2502 paraoxonase 1 NP_000437.3 IQNILTEEPK 118 592.8297 603.2979 paraoxonase 1 NP_000437.3 IQNILTEEPK 118 592.8297 716.382 paraoxonase 1 NP_000437.3 IQNILTEEPK 118 592.8297 829.466 paraoxonase 1 NP_000437.3 IQNILTEEPK 118 592.8297 943.5089 paraoxonase 1 NP_000437.3 IQNILTEEPK 118 592.8297 1071.568 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 438.2342 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 509.2713 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 580.3084 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 708.3669 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 807.4354 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 904.4882 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 1001.541 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 1102.589 beta globin NP_000509.1 EFTPPVQAAYQK 119 689.8537 1249.657 histidine-rich glycoprotein precursor NP_000403.1 ALDLINKR 120 471.7902 417.2563 histidine-rich glycoprotein precursor NP_000403.1 ALDLINKR 120 471.7902 530.3403 histidine-rich glycoprotein precursor NP_000403.1 ALDLINKR 120 471.7902 643.4244 histidine-rich glycoprotein precursor NP_000403.1 ALDLINKR 120 471.7902 758.4514 histidine-rich glycoprotein precursor NP_000403.1 ALDLINKR 120 471.7902 871.5354 apolipoprotein B precursor NP_000375.2 QSFDLSVK 121 462.2453 333.2127 apolipoprotein B precursor NP_000375.2 QSFDLSVK 121 462.2453 446.2968 apolipoprotein B precursor NP_000375.2 QSFDLSVK 121 462.2453 561.3237 apolipoprotein B precursor NP_000375.2 QSFDLSVK 121 462.2453 708.3921 apolipoprotein B precursor NP_000375.2 QSFDLSVK 121 462.2453 795.4241 ceruloplasmin precursor NP_000087.1 DDEEFIESNK 122 613.2646 348.1872 ceruloplasmin precursor NP_000087.1 DDEEFIESNK 122 613.2646 477.2298 ceruloplasmin precursor NP_000087.1 DDEEFIESNK 122 613.2646 590.3138 ceruloplasmin precursor NP_000087.1 DDEEFIESNK 122 613.2646 737.3823 ceruloplasmin precursor NP_000087.1 DDEEFIESNK 122 613.2646 866.4249 ceruloplasmin precursor NP_000087.1 DDEEFIESNK 122 613.2646 995.4675 ceruloplasmin precursor NP_000087.1 DDEEFIESNK 122 613.2646 1110.494 apolipoprotein B precursor NP_000375.2 LSNVLQQVK 123 514.8086 374.2393 apolipoprotein B precursor NP_000375.2 LSNVLQQVK 123 514.8086 502.2978 apolipoprotein B precursor NP_000375.2 LSNVLQQVK 123 514.8086 615.3819 apolipoprotein B precursor NP_000375.2 LSNVLQQVK 123 514.8086 714.4503 apolipoprotein B precursor NP_000375.2 LSNVLQQVK 123 514.8086 828.4932 apolipoprotein B precursor NP_000375.2 LSNVLQQVK 123 514.8086 915.5253 alpha-2-macroglobulin precursor NP_000005.2 GEAFTLK 124 383.2107 361.244 alpha-2-macroglobulin precursor NP_000005.2 GEAFTLK 124 383.2107 508.3124 alpha-2-macroglobulin precursor NP_000005.2 GEAFTLK 124 383.2107 579.3495 alpha-2-macroglobulin precursor NP_000005.2 GEAFTLK 124 383.2107 708.3921 apolipoprotein B precursor NP_000375.2 LFLEETK 125 440.2448 377.2025 apolipoprotein B precursor NP_000375.2 LFLEETK 125 440.2448 506.2451 apolipoprotein B precursor NP_000375.2 LFLEETK 125 440.2448 619.3292 apolipoprotein B precursor NP_000375.2 LFLEETK 125 440.2448 766.3976 apolipoprotein B precursor NP_000375.2 YEGLQEWEGK 126 619.788 333.1763 apolipoprotein B precursor NP_000375.2 YEGLQEWEGK 126 619.788 519.2556 apolipoprotein B precursor NP_000375.2 YEGLQEWEGK 126 619.788 648.2982 apolipoprotein B precursor NP_000375.2 YEGLQEWEGK 126 619.788 776.3568 apolipoprotein B precursor NP_000375.2 YEGLQEWEGK 126 619.788 889.4409 apolipoprotein B precursor NP_000375.2 YEGLQEWEGK 126 619.788 946.4623 apolipoprotein B precursor NP_000375.2 YEGLQEWEGK 126 619.788 1075.505 apolipoprotein B precursor NP_000375.2 INDVLEHVK 127 533.7982 383.2396 apolipoprotein B precursor NP_000375.2 INDVLEHVK 127 533.7982 512.2822 apolipoprotein B precursor NP_000375.2 INDVLEHVK 127 533.7982 625.3662 apolipoprotein B precursor NP_000375.2 INDVLEHVK 127 533.7982 724.4346 apolipoprotein B precursor NP_000375.2 INDVLEHVK 127 533.7982 839.4616 apolipoprotein B precursor NP_000375.2 INDVLEHVK 127 533.7982 953.5045 apolipoprotein B precursor NP_000375.2 IISDYHQQFR 128 653.8306 450.2454 apolipoprotein B precursor NP_000375.2 IISDYHQQFR 128 653.8306 578.304 apolipoprotein B precursor NP_000375.2 IISDYHQQFR 128 653.8306 715.3629 apolipoprotein B precursor NP_000375.2 IISDYHQQFR 128 653.8306 878.4262 apolipoprotein B precursor NP_000375.2 IISDYHQQFR 128 653.8306 993.4531 apolipoprotein B precursor NP_000375.2 IISDYHQQFR 128 653.8306 1080.485 apolipoprotein B precursor NP_000375.2 IISDYHQQFR 128 653.8306 1193.569 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 388.2549 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 503.2818 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 560.3033 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 631.3404 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 794.4037 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 895.4514 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 1009.494 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 1108.563 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 1237.605 apolipoprotein A-IV precursor NP_000473.2 LGEVNTYAGDLQK 129 704.3594 1294.627 alpha 1 globin NP_000549.1 LRVDPVNFK 130 544.3166 408.2236 alpha 1 globin NP_000549.1 LRVDPVNFK 130 544.3166 507.292 alpha 1 globin NP_000549.1 LRVDPVNFK 130 544.3166 604.3448 alpha 1 globin NP_000549.1 LRVDPVNFK 130 544.3166 719.3717 alpha 1 globin NP_000549.1 LRVDPVNFK 130 544.3166 818.4401 alpha 1 globin NP_000549.1 LRVDPVNFK 130 544.3166 974.5413 pregnancy-zone protein NP_002855.1 DLKPAIVK 131 442.2842 359.2647 pregnancy-zone protein NP_002855.1 DLKPAIVK 131 442.2842 430.3018 pregnancy-zone protein NP_002855.1 DLKPAIVK 131 442.2842 527.3546 pregnancy-zone protein NP_002855.1 DLKPAIVK 131 442.2842 655.4496 pregnancy-zone protein NP_002855.1 DLKPAIVK 131 442.2842 768.5336 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 432.2196 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 545.3036 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 642.3564 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 770.415 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 827.4365 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 898.4736 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 1011.558 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 1098.59 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 1155.611 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 1254.68 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 1355.727 apolipoprotein E precursor NP_000032.1 AATVGSLAGQPLQER 132 749.4046 1426.764 histidine-rich glycoprotein precursor NP_000403.1 ALDLINK 133 393.7396 374.2393 histidine-rich glycoprotein precursor NP_000403.1 ALDLINK 133 393.7396 487.3233 histidine-rich glycoprotein precursor NP_000403.1 ALDLINK 133 393.7396 602.3503 histidine-rich glycoprotein precursor NP_000403.1 ALDLINK 133 393.7396 715.4343 alpha-2-macroglobulin precursor NP_000005.2 FEVQVTVPK 134 523.7977 343.2334 alpha-2-macroglobulin precursor NP_000005.2 FEVQVTVPK 134 523.7977 444.2811 alpha-2-macroglobulin precursor NP_000005.2 FEVQVTVPK 134 523.7977 543.3495 alpha-2-macroglobulin precursor NP_000005.2 FEVQVTVPK 134 523.7977 671.4081 alpha-2-macroglobulin precursor NP_000005.2 FEVQVTVPK 134 523.7977 770.4765 alpha-2-macroglobulin precursor NP_000005.2 FEVQVTVPK 134 523.7977 899.5191 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 363.1869 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 462.2553 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 576.2982 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 704.3568 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 817.4409 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 1003.52 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 1090.552 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 1161.589 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 1262.637 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 1349.669 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 1436.701 apolipoprotein B precursor NP_000375.2 SGSSTASWIQNVDTK 135 790.8812 1493.723 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 136 647.3379 391.1818 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 136 647.3379 504.2659 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 136 647.3379 605.3135 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 136 647.3379 719.3564 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 136 647.3379 776.3779 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 136 647.3379 923.4464 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 136 647.3379 1180.584 apolipoprotein B precursor NP_000375.2 QGFFPDSVNK 137 569.78 360.2236 apolipoprotein B precursor NP_000375.2 QGFFPDSVNK 137 569.78 447.2556 apolipoprotein B precursor NP_000375.2 QGFFPDSVNK 137 569.78 562.2826 apolipoprotein B precursor NP_000375.2 QGFFPDSVNK 137 569.78 659.3353 apolipoprotein B precursor NP_000375.2 QGFFPDSVNK 137 569.78 806.4037 apolipoprotein B precursor NP_000375.2 QGFFPDSVNK 137 569.78 953.4722 apolipoprotein B precursor NP_000375.2 QGFFPDSVNK 137 569.78 1010.494 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 361.1825 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 474.2665 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 637.3298 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 784.3983 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 885.4459 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 972.478 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 1087.505 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 1216.547 ceruloplasmin precursor NP_000087.1 QSEDSTFYLGER 138 716.323 1303.58 apolipoprotein B precursor NP_000375.2 INPLALK 139 384.7525 331.2334 apolipoprotein B precursor NP_000375.2 INPLALK 139 384.7525 444.3175 apolipoprotein B precursor NP_000375.2 INPLALK 139 384.7525 541.3702 apolipoprotein B precursor NP_000375.2 INPLALK 139 384.7525 655.4132 apolipoprotein B precursor NP_000375.2 LNELSFK 140 425.7371 381.2127 apolipoprotein B precursor NP_000375.2 LNELSFK 140 425.7371 494.2968 apolipoprotein B precursor NP_000375.2 LNELSFK 140 425.7371 623.3394 apolipoprotein B precursor NP_000375.2 LNELSFK 140 425.7371 737.3823 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 362.2029 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 525.2662 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 596.3033 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 711.3303 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 824.4143 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 939.4412 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 1067.5 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 1154.532 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 1317.595 apolipoprotein B precursor NP_000375.2 TQFNNNEYSQDLDAYNTK 141 1082.974 1446.638 apolipoprotein B precursor NP_000375.2 LSLPDFK 142 410.2342 409.2076 apolipoprotein B precursor NP_000375.2 LSLPDFK 142 410.2342 506.2604 apolipoprotein B precursor NP_000375.2 LSLPDFK 142 410.2342 619.3444 apolipoprotein B precursor NP_000375.2 LSLPDFK 142 410.2342 706.3765 apolipoprotein B precursor NP_000375.2 VSTAFVYTK 143 508.2766 411.2233 apolipoprotein B precursor NP_000375.2 VSTAFVYTK 143 508.2766 510.2917 apolipoprotein B precursor NP_000375.2 VSTAFVYTK 143 508.2766 657.3601 apolipoprotein B precursor NP_000375.2 VSTAFVYTK 143 508.2766 728.3972 apolipoprotein B precursor NP_000375.2 VSTAFVYTK 143 508.2766 829.4449 apolipoprotein B precursor NP_000375.2 VSTAFVYTK 143 508.2766 916.4769 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 305.1814 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 376.2185 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 473.2713 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 588.2982 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 701.3823 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 788.4143 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 885.4671 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 998.5511 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 1085.583 apolipoprotein B precursor NP_000375.2 SVSLPSLDPASAK 144 636.3457 1184.652 pregnancy-zone protein NP_002855.1 EDSPFALK 145 453.732 331.2334 pregnancy-zone protein NP_002855.1 EDSPFALK 145 453.732 478.3018 pregnancy-zone protein NP_002855.1 EDSPFALK 145 453.732 575.3546 pregnancy-zone protein NP_002855.1 EDSPFALK 145 453.732 662.3867 pregnancy-zone protein NP_002855.1 EDSPFALK 145 453.732 777.4136 apolipoprotein B precursor NP_000375.2 DSYDLHDLK 146 553.2617 375.2233 apolipoprotein B precursor NP_000375.2 DSYDLHDLK 146 553.2617 512.2822 apolipoprotein B precursor NP_000375.2 DSYDLHDLK 146 553.2617 625.3662 apolipoprotein B precursor NP_000375.2 DSYDLHDLK 146 553.2617 740.3932 apolipoprotein B precursor NP_000375.2 DSYDLHDLK 146 553.2617 903.4565 apolipoprotein B precursor NP_000375.2 DSYDLHDLK 146 553.2617 990.4885 apolipoprotein D precursor NP_001638.1 WYEIEK 147 434.216 389.2389 apolipoprotein D precursor NP_001638.1 WYEIEK 147 434.216 518.2815 apolipoprotein D precursor NP_001638.1 WYEIEK 147 434.216 681.3448 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 360.1985 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 461.2461 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 575.2891 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 738.3524 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 825.3844 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 972.4528 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 1085.537 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 1172.569 serum amyloid P component precursor NP_001630.1 AYSLFSYNTQGR 148 703.8386 1335.632 histidine-rich glycoprotein precursor NP_000403.1 EENDDFASFR 149 615.2571 409.2188 histidine-rich glycoprotein precursor NP_000403.1 EENDDFASFR 149 615.2571 480.256 histidine-rich glycoprotein precursor NP_000403.1 EENDDFASFR 149 615.2571 627.3244 histidine-rich glycoprotein precursor NP_000403.1 EENDDFASFR 149 615.2571 742.3513 histidine-rich glycoprotein precursor NP_000403.1 EENDDFASFR 149 615.2571 857.3782 histidine-rich glycoprotein precursor NP_000403.1 EENDDFASFR 149 615.2571 971.4212 histidine-rich glycoprotein precursor NP_000403.1 EENDDFASFR 149 615.2571 1100.464 apolipoprotein B precursor NP_000375.2 AQIPILR 150 405.7634 401.2865 apolipoprotein B precursor NP_000375.2 AQIPILR 150 405.7634 498.3393 apolipoprotein B precursor NP_000375.2 AQIPILR 150 405.7634 611.4233 apolipoprotein B precursor NP_000375.2 AQIPILR 150 405.7634 739.4819 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 450.2454 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 565.2723 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 666.32 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 767.3677 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 881.4106 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 996.4376 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 1093.49 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 1256.554 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 1369.638 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 1440.675 ceruloplasmin precursor NP_000087.1 EHEGAIYPDNTTDFQR 151 946.9241 1497.696 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 333.1875 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 446.2716 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 574.3302 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 688.3731 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 789.4208 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 846.4423 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 974.5009 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 1087.585 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 1250.648 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 1337.68 apolipoprotein B precursor NP_000375.2 FNSSYLQGTNQITGR 152 843.4157 1424.712 pregnancy-zone protein NP_002855.1 EILNSLDK 153 466.2584 375.2233 pregnancy-zone protein NP_002855.1 EILNSLDK 153 466.2584 462.2553 pregnancy-zone protein NP_002855.1 EILNSLDK 153 466.2584 576.2982 pregnancy-zone protein NP_002855.1 EILNSLDK 153 466.2584 689.3823 pregnancy-zone protein NP_002855.1 EILNSLDK 153 466.2584 802.4664 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 347.2283 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 462.2553 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 561.3237 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 662.3714 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 791.414 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 888.4667 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 985.5195 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 1098.604 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 1212.646 apolipoprotein D precursor NP_001638.1 NPNLPPETVDSLK 154 712.375 1309.699 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 417.2451 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 532.272 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 619.304 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 782.3674 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 879.4201 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 950.4572 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 1063.541 apolipoprotein A-I preproprotein NP_000030.1 THLAPYSDELR 155 651.3279 1200.6 apolipoprotein E precursor NP_000032.1 QWAGLVEK 156 465.7558 375.2233 apolipoprotein E precursor NP_000032.1 QWAGLVEK 156 465.7558 488.3073 apolipoprotein E precursor NP_000032.1 QWAGLVEK 156 465.7558 545.3288 apolipoprotein E precursor NP_000032.1 QWAGLVEK 156 465.7558 616.3659 apolipoprotein E precursor NP_000032.1 QWAGLVEK 156 465.7558 802.4452 paraoxonase 1 NP_000437.3 STVELFK 157 412.2316 407.2647 paraoxonase 1 NP_000437.3 STVELFK 157 412.2316 536.3073 paraoxonase 1 NP_000437.3 STVELFK 157 412.2316 635.3757 paraoxonase 1 NP_000437.3 STVELFK 157 412.2316 736.4234 apolipoprotein A-IV precursor NP_000473.2 ALVQQMEQLR 158 608.3293 416.261 apolipoprotein A-IV precursor NP_000473.2 ALVQQMEQLR 158 608.3293 545.3036 apolipoprotein A-IV precursor NP_000473.2 ALVQQMEQLR 158 608.3293 676.3441 apolipoprotein A-IV precursor NP_000473.2 ALVQQMEQLR 158 608.3293 804.4027 apolipoprotein A-IV precursor NP_000473.2 ALVQQMEQLR 158 608.3293 932.4613 apolipoprotein A-IV precursor NP_000473.2 ALVQQMEQLR 158 608.3293 1031.53 apolipoprotein A-IV precursor NP_000473.2 ALVQQMEQLR 158 608.3293 1144.614 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 376.1821 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 477.2298 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 606.2724 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 721.2993 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 820.3677 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 967.4362 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 1095.495 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 1232.554 apolipoprotein B precursor NP_000375.2 SFDYHQFVDETNDK 159 872.8761 1395.617 apolipoprotein B precursor NP_000375.2 QVFLYPEK 160 512.2791 373.2076 apolipoprotein B precursor NP_000375.2 QVFLYPEK 160 512.2791 536.2709 apolipoprotein B precursor NP_000375.2 QVFLYPEK 160 512.2791 649.355 apolipoprotein B precursor NP_000375.2 QVFLYPEK 160 512.2791 796.4234 apolipoprotein B precursor NP_000375.2 QVFLYPEK 160 512.2791 895.4918 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.7986 305.1814 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.7986 434.224 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.7986 783.3666 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.7986 870.3987 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.7986 957.4307 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.7986 1070.515 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.7986 1157.547 pregnancy-zone protein NP_002855.1 GEVFTLK 162 397.2263 361.244 pregnancy-zone protein NP_002855.1 GEVFTLK 162 397.2263 508.3124 pregnancy-zone protein NP_002855.1 GEVFTLK 162 397.2263 607.3808 pregnancy-zone protein NP_002855.1 GEVFTLK 162 397.2263 736.4234 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 363.1804 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 462.2488 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 577.2757 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 664.3077 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 793.3503 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 956.4136 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 1103.482 alpha-2-macroglobulin precursor NP_000005.2 VGFYESDVM[Oxid]GR 163 630.2899 1160.504 apolipoprotein B precursor NP_000375.2 YENYELTLK 164 586.7953 361.244 apolipoprotein B precursor NP_000375.2 YENYELTLK 164 586.7953 474.3281 apolipoprotein B precursor NP_000375.2 YENYELTLK 164 586.7953 603.3707 apolipoprotein B precursor NP_000375.2 YENYELTLK 164 586.7953 766.434 apolipoprotein B precursor NP_000375.2 YENYELTLK 164 586.7953 880.4769 apolipoprotein B precursor NP_000375.2 YENYELTLK 164 586.7953 1009.52 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 331.2334 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 445.2764 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 559.3193 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 672.4034 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 785.4874 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 872.5195 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 929.5409 pregnancy-zone protein NP_002855.1 SSGSLLNNAIK 165 552.3064 1016.573 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 388.2913 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 501.3753 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 598.4281 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 699.4758 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 812.5599 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 940.6184 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 1069.661 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIKK 166 642.8979 1197.756 pregnancy-zone protein NP_002855.1 QTLSWTVTPK 167 580.8192 345.2127 pregnancy-zone protein NP_002855.1 QTLSWTVTPK 167 580.8192 444.2811 pregnancy-zone protein NP_002855.1 QTLSWTVTPK 167 580.8192 545.3288 pregnancy-zone protein NP_002855.1 QTLSWTVTPK 167 580.8192 731.4081 pregnancy-zone protein NP_002855.1 QTLSWTVTPK 167 580.8192 818.4401 pregnancy-zone protein NP_002855.1 QTLSWTVTPK 167 580.8192 931.5242 pregnancy-zone protein NP_002855.1 QTLSWTVTPK 167 580.8192 1032.572 apolipoprotein B precursor NP_000375.2 IPSVQINFK 168 523.3057 408.2236 apolipoprotein B precursor NP_000375.2 IPSVQINFK 168 523.3057 521.3077 apolipoprotein B precursor NP_000375.2 IPSVQINFK 168 523.3057 649.3662 apolipoprotein B precursor NP_000375.2 IPSVQINFK 168 523.3057 748.4346 apolipoprotein B precursor NP_000375.2 IPSVQINFK 168 523.3057 835.4667 apolipoprotein B precursor NP_000375.2 IPSVQINFK 168 523.3057 932.5195 apolipoprotein B precursor NP_000375.2 IYSLWEHSTK 169 632.322 335.192 apolipoprotein B precursor NP_000375.2 IYSLWEHSTK 169 632.322 472.2509 apolipoprotein B precursor NP_000375.2 IYSLWEHSTK 169 632.322 601.2935 apolipoprotein B precursor NP_000375.2 IYSLWEHSTK 169 632.322 787.3728 apolipoprotein B precursor NP_000375.2 IYSLWEHSTK 169 632.322 900.4568 apolipoprotein B precursor NP_000375.2 IYSLWEHSTK 169 632.322 987.4889 apolipoprotein B precursor NP_000375.2 IYSLWEHSTK 169 632.322 1150.552 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 170 615.8381 361.2076 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 170 615.8381 474.2917 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 170 615.8381 588.3346 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 170 615.8381 702.3775 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 170 615.8381 789.4095 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 170 615.8381 890.4572 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 170 615.8381 1116.625 apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 409.1746 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 538.2172 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 651.3013 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 780.3439 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 909.3864 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 1006.439 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 1063.461 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 1178.488 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 1291.572 DGPEEIEC[Carboxymethyl]TK apolipoprotein H precursor NP_000033.1 ATFGC[Carboxymethyl]HDGYSL 171 1194.486 1378.604 DGPEEIEC[Carboxymethyl]TK apolipoprotein B precursor NP_000375.2 FPEVDVLTK 172 524.2897 361.244 apolipoprotein B precursor NP_000375.2 FPEVDVLTK 172 524.2897 460.3124 apolipoprotein B precursor NP_000375.2 FPEVDVLTK 172 524.2897 575.3394 apolipoprotein B precursor NP_000375.2 FPEVDVLTK 172 524.2897 674.4078 apolipoprotein B precursor NP_000375.2 FPEVDVLTK 172 524.2897 803.4504 apolipoprotein B precursor NP_000375.2 FPEVDVLTK 172 524.2897 900.5031 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 397.2076 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 496.276 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 624.3346 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 711.3666 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 824.4507 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 923.5191 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 1024.567 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 1081.588 apolipoprotein B precursor NP_000375.2 EVGTVLSQVYSK 173 655.3535 1180.657 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 361.244 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 489.3026 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 590.3503 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 689.4186 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 817.4772 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 888.5143 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 987.5828 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 1118.623 apolipoprotein B precursor NP_000375.2 YGMVAQVTQTLK 174 669.8579 1175.645 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002 357.2491 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002 520.3124 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002 634.3553 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002 846.5078 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002 947.5555 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 315.2021 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 444.2447 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 545.2924 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 658.3765 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 772.4194 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 871.4878 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 968.5406 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 1069.588 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 1140.625 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 1269.668 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 1326.689 apolipoprotein D precursor NP_001638.1 ADGTVNQIEGEATPVNLTEPAK 176 1127.563 1455.732 serum amyloid P component precursor NP_001630.1 VGEYSLYIGR 177 578.8035 345.2239 serum amyloid P component precursor NP_001630.1 VGEYSLYIGR 177 578.8035 508.2873 serum amyloid P component precursor NP_001630.1 VGEYSLYIGR 177 578.8035 621.3713 serum amyloid P component precursor NP_001630.1 VGEYSLYIGR 177 578.8035 871.4667 serum amyloid P component precursor NP_001630.1 VGEYSLYIGR 177 578.8035 1000.509 serum amyloid P component precursor NP_001630.1 VGEYSLYIGR 177 578.8035 1057.531 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIK 178 578.8505 373.2804 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIK 178 578.8505 470.3332 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIK 178 578.8505 571.3808 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIK 178 578.8505 684.4649 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIK 178 578.8505 812.5234 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIK 178 578.8505 1069.661 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 405.2087 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 534.2513 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 605.2884 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 704.3568 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 801.4095 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 902.4572 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 1015.541 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 1143.6 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 1272.642 apolipoprotein E precursor NP_000032.1 SELEEQLTPVAEETR 179 865.9258 1401.685 apolipoprotein B precursor NP_000375.2 FIIPGLK 180 394.2574 317.2178 apolipoprotein B precursor NP_000375.2 FIIPGLK 180 394.2574 414.2705 apolipoprotein B precursor NP_000375.2 FIIPGLK 180 394.2574 527.3546 apolipoprotein B precursor NP_000375.2 FIIPGLK 180 394.2574 640.4387 apolipoprotein A-II preproprotein NP_001634.1 EQLTPLIK 181 471.287 373.2804 apolipoprotein A-II preproprotein NP_001634.1 EQLTPLIK 181 471.287 470.3332 apolipoprotein A-II preproprotein NP_001634.1 EQLTPLIK 181 471.287 571.3808 apolipoprotein A-II preproprotein NP_001634.1 EQLTPLIK 181 471.287 684.4649 apolipoprotein A-II preproprotein NP_001634.1 EQLTPLIK 181 471.287 812.5234 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 275.1708 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 388.2549 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 525.3138 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 653.3724 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 766.4564 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 881.4834 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 994.5674 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 1108.61 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 1236.669 apolipoprotein B precursor NP_000375.2 HIQNIDIQHLAGK 182 743.9099 1349.753 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 359.192 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 446.224 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 533.256 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 661.3146 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 758.3674 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 845.3994 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 1008.463 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 1171.526 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 1318.594 apolipoprotein B precursor NP_000375.2 WNFYYSPQSSPDK 183 809.8622 1432.637 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 447.2345 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 561.2774 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 675.3204 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 774.3888 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 845.4259 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 982.4848 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 1069.517 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 1182.601 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 1253.638 apolipoprotein B precursor NP_000375.2 ATLYALSHAVNNYHK 184 851.439 1416.701 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 439.2182 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 602.2815 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 717.3085 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 804.3405 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 917.4246 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 1045.483 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 1160.51 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 1247.542 apolipoprotein B precursor NP_000375.2 LQDFSDQLSDYYEK 185 875.894 1394.61 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 363.1869 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 462.2553 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 576.2982 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 677.3459 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 734.3674 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 835.415 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 949.4579 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 1135.537 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 1264.58 apolipoprotein B precursor NP_000375.2 IEFEWNTGTNVDTK 186 827.3914 1411.648 apolipoprotein B precursor NP_000375.2 DFSLWEK 187 462.7267 462.2342 apolipoprotein B precursor NP_000375.2 DFSLWEK 187 462.7267 575.3182 apolipoprotein B precursor NP_000375.2 DFSLWEK 187 462.7267 662.3503 apolipoprotein B precursor NP_000375.2 DFSLWEK 187 462.7267 809.4186 serum amyloid P component precursor NP_001630.1 DNELLVYK 188 497.2662 409.244 serum amyloid P component precursor NP_001630.1 DNELLVYK 188 497.2662 522.3281 serum amyloid P component precursor NP_001630.1 DNELLVYK 188 497.2662 635.4121 serum amyloid P component precursor NP_001630.1 DNELLVYK 188 497.2662 764.4547 serum amyloid P component precursor NP_001630.1 DNELLVYK 188 497.2662 878.4976 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 441.2199 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 554.304 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 683.3466 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 784.3942 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 855.4313 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 1002.5 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 1099.552 apolipoprotein A-IV precursor NP_000473.2 LVPFATELHER 189 656.3564 1198.621 apolipoprotein B precursor NP_000375.2 NLLVALK 190 385.7604 331.2334 apolipoprotein B precursor NP_000375.2 NLLVALK 190 385.7604 430.3018 apolipoprotein B precursor NP_000375.2 NLLVALK 190 385.7604 543.3859 apolipoprotein B precursor NP_000375.2 NLLVALK 190 385.7604 656.47 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 363.1869 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 491.2455 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 590.3138 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 737.3823 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 836.4507 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 949.5347 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 1036.567 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 1151.594 alpha-2-macroglobulin precursor NP_000005.2 NEDSLVFVQTDK 191 697.8436 1280.636 apolipoprotein E precursor NP_000032.1 FWDYLR 192 450.2242 451.2658 apolipoprotein E precursor NP_000032.1 FWDYLR 192 450.2242 752.3721 paraoxonase 1 NP_000437.3 HANWTLTPLK 193 590.8273 357.2491 paraoxonase 1 NP_000437.3 HANWTLTPLK 193 590.8273 458.2968 paraoxonase 1 NP_000437.3 HANWTLTPLK 193 590.8273 571.3808 paraoxonase 1 NP_000437.3 HANWTLTPLK 193 590.8273 672.4285 paraoxonase 1 NP_000437.3 HANWTLTPLK 193 590.8273 858.5078 paraoxonase 1 NP_000437.3 HANWTLTPLK 193 590.8273 972.5507 paraoxonase 1 NP_000437.3 HANWTLTPLK 193 590.8273 1043.588 alpha 1 globin NP_000549.1 MFLSFPTTK 194 536.2808 349.2076 alpha 1 globin NP_000549.1 MFLSFPTTK 194 536.2808 446.2604 alpha 1 globin NP_000549.1 MFLSFPTTK 194 536.2808 593.3288 alpha 1 globin NP_000549.1 MFLSFPTTK 194 536.2808 680.3608 alpha 1 globin NP_000549.1 MFLSFPTTK 194 536.2808 793.4449 alpha 1 globin NP_000549.1 MFLSFPTTK 194 536.2808 940.5133 apolipoprotein B precursor NP_000375.2 DNVFDGLVR 195 517.7669 387.2709 apolipoprotein B precursor NP_000375.2 DNVFDGLVR 195 517.7669 444.2924 apolipoprotein B precursor NP_000375.2 DNVFDGLVR 195 517.7669 559.3193 apolipoprotein B precursor NP_000375.2 DNVFDGLVR 195 517.7669 706.3877 apolipoprotein B precursor NP_000375.2 DNVFDGLVR 195 517.7669 805.4561 apolipoprotein B precursor NP_000375.2 DNVFDGLVR 195 517.7669 919.499 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 372.2236 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 485.3076 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 614.3503 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 727.4343 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 798.4714 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 926.53 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 1039.614 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 1168.657 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 1225.678 apolipoprotein B precursor NP_000375.2 LNGEIQALELPQK 196 726.9065 1339.721 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 319.1971 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 432.2811 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 531.3495 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 618.3815 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 755.4405 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 812.4619 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 911.5303 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 1048.589 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 1176.648 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 1263.68 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 1378.707 apolipoprotein B precursor NP_000375.2 LEIQSQVDSQHVGHSVLTAK 197 1088.572 1477.775 apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 361.2188 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 524.2822 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 581.3036 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 678.3564 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 806.4514 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 967.466 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 1054.498 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 1217.561 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 1318.609 KPGYVSR apolipoprotein H precursor NP_000033.1 TFYEPGEEITYSC[Carboxymethyl] 198 1192.541 1431.693 KPGYVSR apolipoprotein A-IV precursor NP_000473.2 VNSFFSTFK 199 538.7742 395.2283 apolipoprotein A-IV precursor NP_000473.2 VNSFFSTFK 199 538.7742 482.2604 apolipoprotein A-IV precursor NP_000473.2 VNSFFSTFK 199 538.7742 629.3288 apolipoprotein A-IV precursor NP_000473.2 VNSFFSTFK 199 538.7742 776.3972 apolipoprotein A-IV precursor NP_000473.2 VNSFFSTFK 199 538.7742 863.4293 apolipoprotein A-IV precursor NP_000473.2 VNSFFSTFK 199 538.7742 977.4722 apolipoprotein H precursor NP_000033.1 EHSSLAFWK 200 552.7773 480.26 apolipoprotein H precursor NP_000033.1 EHSSLAFWK 200 552.7773 551.2971 apolipoprotein H precursor NP_000033.1 EHSSLAFWK 200 552.7773 664.3812 apolipoprotein H precursor NP_000033.1 EHSSLAFWK 200 552.7773 751.4132 apolipoprotein H precursor NP_000033.1 EHSSLAFWK 200 552.7773 838.4452 apolipoprotein H precursor NP_000033.1 EHSSLAFWK 200 552.7773 975.5042 paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 359.2647 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 473.3076 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 634.3223 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 748.3652 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 845.418 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 958.5021 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 1087.545 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 1186.613 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 1283.666 VK paraoxonase 1 NP_000437.3 EVQPVELPNC[Carboxymethyl]NL 201 820.4216 1411.724 VK apolipoprotein B precursor NP_000375.2 LVGFIDDAVK 202 538.803 317.2178 apolipoprotein B precursor NP_000375.2 LVGFIDDAVK 202 538.803 432.2447 apolipoprotein B precursor NP_000375.2 LVGFIDDAVK 202 538.803 547.2717 apolipoprotein B precursor NP_000375.2 LVGFIDDAVK 202 538.803 660.3557 apolipoprotein B precursor NP_000375.2 LVGFIDDAVK 202 538.803 807.4241 apolipoprotein B precursor NP_000375.2 LVGFIDDAVK 202 538.803 864.4456 apolipoprotein B precursor NP_000375.2 LVGFIDDAVK 202 538.803 963.514 apolipoprotein E precursor NP_000032.1 WELALGR 203 422.7374 345.2239 apolipoprotein E precursor NP_000032.1 WELALGR 203 422.7374 416.261 apolipoprotein E precursor NP_000032.1 WELALGR 203 422.7374 529.3451 apolipoprotein E precursor NP_000032.1 WELALGR 203 422.7374 658.3877 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 333.2127 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 390.2342 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 505.2611 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 602.3138 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 701.3823 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 829.4409 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 886.4623 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 1000.505 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 1099.574 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 1285.653 apolipoprotein B precursor NP_000375.2 ALYWVNGQVPDGVSK 204 816.9227 1448.716 apolipoprotein H precursor NP_000033.1 ATVVYQGER 205 511.7669 652.3044 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 397.2076 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 468.2447 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 555.2767 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 668.3608 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 739.3979 apolipoprotein B precursor NP_000375. HIYAISSAALSASYK 206 791.4172 810.4351 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 897.4671 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 984.4991 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 1097.583 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 1168.62 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 1331.684 apolipoprotein B precursor NP_000375.2 HIYAISSAALSASYK 206 791.4172 1444.768 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 319.1719 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 420.2196 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 583.2829 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 670.3149 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 769.3834 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 856.4153 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 969.4995 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 1056.531 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 1169.615 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 1297.674 alpha-2-macroglobulin precursor NP_000005.2 AHTSFQISLSVSYTGSR 207 920.963 1444.743 apolipoprotein B precursor NP_000375.2 NIILPVYDK 208 537.8134 425.2025 apolipoprotein B precursor NP_000375.2 NIILPVYDK 208 537.8134 524.2709 apolipoprotein B precursor NP_000375.2 NIILPVYDK 208 537.8134 621.3237 apolipoprotein B precursor NP_000375.2 NIILPVYDK 208 537.8134 734.4078 apolipoprotein B precursor NP_000375.2 NIILPVYDK 208 537.8134 847.4918 apolipoprotein B precursor NP_000375.2 NIILPVYDK 208 537.8134 960.5759 apolipoprotein B precursor NP_000375.2 IEIPLPFGGK 209 535.8159 261.1552 apolipoprotein B precursor NP_000375.2 IEIPLPFGGK 209 535.8159 408.2236 apolipoprotein B precursor NP_000375.2 IEIPLPFGGK 209 535.8159 505.2764 apolipoprotein B precursor NP_000375.2 IEIPLPFGGK 209 535.8159 618.3604 apolipoprotein B precursor NP_000375.2 IEIPLPFGGK 209 535.8159 715.4132 apolipoprotein B precursor NP_000375.2 IEIPLPFGGK 209 535.8159 828.4973 apolipoprotein B precursor NP_000375.2 IEIPLPFGGK 209 535.8159 957.5399 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 422.2393 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 523.2869 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 652.3295 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 739.3616 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 886.4299 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 1072.509 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 1201.552 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 744.8506 1357.653 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 422.2393 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 523.2869 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 652.3295 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 739.3616 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 886.4299 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 1072.509 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 1201.552 apolipoprotein C-I precursor NP_001636.1 MREWFSETFQK 210 752.8481 1357.653 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 363.1869 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 491.2455 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 604.3295 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 691.3616 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 820.4041 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 933.4882 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 1096.552 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 1195.62 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 1266.657 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 1365.725 apolipoprotein B precursor NP_000375.2 ATVAVYLESLQDTK 211 769.4091 1466.773 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 375.2345 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 446.2716 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 583.3305 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 696.4146 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 767.4517 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 866.5201 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 965.5885 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 1066.636 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 1181.663 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 1309.722 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 1410.769 pregnancy-zone protein NP_002855.1 QQNAQGGFSSTQDTVVALHALSR 212 1208.104 1497.801 paraoxonase 1 NP_000437.3 LLIGTVFHK 213 514.3186 431.2396 paraoxonase 1 NP_000437.3 LLIGTVFHK 213 514.3186 530.308 paraoxonase 1 NP_000437.3 LLIGTVFHK 213 514.3186 631.3557 paraoxonase 1 NP_000437.3 LLIGTVFHK 213 514.3186 688.3771 paraoxonase 1 NP_000437.3 LLIGTVFHK 213 514.3186 801.4612 paraoxonase 1 NP_000437.3 LLIGTVFHK 213 514.3186 914.5453 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 434.2393 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 491.2607 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 592.3084 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 720.3669 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 849.4095 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 920.4467 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 1017.499 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 1118.547 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 1231.631 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 1344.715 apolipoprotein B precursor NP_000375.2 VSALLTPAEQTGTWK 214 801.4303 1415.752 apolipoprotein C-I precursor NP_001636.1 EWFSETFQK 215 601.2798 422.2393 apolipoprotein C-I precursor NP_001636.1 EWFSETFQK 215 601.2798 523.2869 apolipoprotein C-I precursor NP_001636.1 EWFSETFQK 215 601.2798 652.3295 apolipoprotein C-I precursor NP_001636.1 EWFSETFQK 215 601.2798 739.3616 apolipoprotein C-I precursor NP_001636.1 EWFSETFQK 215 601.2798 886.4299 apolipoprotein C-I precursor NP_001636.1 EWFSETFQK 215 601.2798 1072.509 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 381.2127 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 495.2556 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 608.3397 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 695.3717 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 752.3932 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 839.4252 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 968.4678 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 1131.531 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 1230.599 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 1343.684 apolipoprotein B precursor NP_000375.2 VNQNLVYESGSLNFSK 216 899.9521 1457.727 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 361.2188 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 508.2873 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 623.3142 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 722.3826 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 869.451 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 1032.514 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 1089.536 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 1190.583 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 1247.605 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 1376.648 histidine-rich glycoprotein precursor NP_000403.1 GGEGTGYFVDFSVR 217 745.8492 1433.669 apolipoprotein B precursor NP_000375.2 DEPTYILNIK 218 603.3243 374.2393 apolipoprotein B precursor NP_000375.2 DEPTYILNIK 218 603.3243 487.3233 apolipoprotein B precursor NP_000375.2 DEPTYILNIK 218 603.3243 600.4073 apolipoprotein B precursor NP_000375.2 DEPTYILNIK 218 603.3243 763.4707 apolipoprotein B precursor NP_000375.2 DEPTYILNIK 218 603.3243 864.5184 apolipoprotein B precursor NP_000375.2 DEPTYILNIK 218 603.3243 961.5712 apolipoprotein B precursor NP_000375.2 DEPTYILNIK 218 603.3243 1090.614 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 418.2039 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 531.288 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 644.3721 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 741.4248 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 838.4776 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 951.5616 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 1050.63 apolipoprotein B precursor NP_000375.2 TEVIPPLIENR 219 640.8641 1179.673 serum amyloid A4; constitutive NP_006503.1 EALQGVGDMGR 220 566.7744 634.2972 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 374.2393 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 445.2764 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 532.3084 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 589.3298 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 726.3888 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 813.4208 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 926.5049 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 1041.532 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 1325.659 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.4496 1422.712 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 423.2345 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 552.2771 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 667.304 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 768.3517 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 931.415 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 1059.474 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 1172.558 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 1335.621 ceruloplasmin precursor NP_000087.1 ALYLQYTDETFR 222 760.375 1448.705 apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 345.2239 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 402.2454 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 516.2883 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 645.3309 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 758.415 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 871.499 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 928.5205 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 999.5576 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 1146.626 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 1243.679 VR apolipoprotein H precursor NP_000033.1 VC[Carboxymethyl]PFAGILENGA 223 752.3848 1404.693 VR apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 389.2389 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 536.3073 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 623.3394 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 736.4234 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 873.4823 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 930.5038 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 1059.546 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 1158.615 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 1273.642 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 1330.663 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 224 903.4626 1401.7 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 399.1981 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 562.2614 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 663.3091 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 764.3568 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 893.3994 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 950.4208 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 1037.453 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 1094.474 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 1222.533 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 1321.601 apolipoprotein B precursor NP_000375.2 ADSVVDLLSYNVQGSGETTYDHK 225 1249.588 1435.644 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 226 598.801 347.2283 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 226 598.801 434.2604 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 226 598.801 581.3288 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 226 598.801 638.3503 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 226 598.801 753.3772 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 226 598.801 953.4933 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 226 598.801 1139.573 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 357.2491 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 458.2968 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 605.3652 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 706.4128 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 803.4656 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 902.5341 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 1030.593 apolipoprotein B precursor NP_000375.2 EFQVPTFTIPK 227 653.8557 1177.661 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 319.1607 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 416.2134 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 531.2404 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 632.288 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 745.3721 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 858.4562 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 945.4882 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 1058.572 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 1221.636 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 1350.678 apolipoprotein B precursor NP_000375.2 NIQEYLSILTDPDGK 228 853.4358 1478.737 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 331.2083 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 444.2924 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 670.3877 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 783.4717 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 870.5038 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 983.5878 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 1080.641 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 1243.704 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 229 686.3852 1314.741 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 395.2283 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 482.2604 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 629.3288 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 776.3972 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 863.4293 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 977.4722 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 1076.541 apolipoprotein A-IV precursor NP_000473.2 DKVNSFFSTFK 230 660.3351 1204.635 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 381.2127 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 482.2604 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 569.2924 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 670.3401 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 769.4085 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 856.4406 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 1157.547 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 1271.59 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 1386.617 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 231 806.8963 1499.701 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 490.2403 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 604.2833 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 751.3516 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 838.3837 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 952.4266 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 1065.511 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 1228.574 apolipoprotein B precursor NP_000375.2 LPQQANDYLNSFNWER 232 997.9714 1343.601 apolipoprotein B precursor NP_000375. LPQQANDYLNSFNWER 232 997.9714 1457.644 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3379 1052.489 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 359.2647 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 458.3332 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 515.3546 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 629.3975 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 716.4296 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 829.5136 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 958.5562 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 1071.64 apolipoprotein B precursor NP_000375.2 NTLELSNGVIVK 234 643.8694 1172.688 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 347.2283 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 461.2713 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 574.3553 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 711.4142 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 826.4412 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 954.4998 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 1067.584 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 1168.631 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 1296.69 apolipoprotein B precursor NP_000375.2 ASGSLPYTQTLQDHLNSLK 235 1037.034 1397.738 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 377.2137 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 434.2352 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 562.2938 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 691.3364 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 838.4048 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 985.4732 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 1084.542 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 1155.579 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 1242.611 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 1357.638 ceruloplasmin precursor NP_000087.1 ENLTAPGSDSAVFFEQGTTR 236 1064.003 1444.67 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 409.244 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 496.276 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 567.3131 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 666.3815 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 767.4293 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 854.4612 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 911.4827 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 1039.541 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 1152.625 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 1251.694 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 1352.741 paraoxonase 1 NP_000437.3 VTQVYAENGTVLQGSTVASVYK 237 1157.6 1409.763 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 238 643.7986 620.3033 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 319.1607 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 418.2291 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 533.256 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 604.2932 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 741.3521 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 854.4361 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 982.4947 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 1079.547 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 1136.569 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 1249.653 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 1362.737 ceruloplasmin precursor NP_000087.1 AEEEHLGILGPQLHADVGDK 239 1064.537 1419.759 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 347.2283 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 444.2811 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 572.3761 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 685.4601 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 782.5129 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 895.597 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 1042.665 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 1099.687 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 1186.719 pregnancy-zone protein NP_002855.1 MVSGFIPLKPTVK 240 708.9178 1285.787 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 355.2083 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 468.2924 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 581.3764 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 710.419 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 781.4561 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 894.5402 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 1057.604 paraoxonase 1 NP_000437.3 YVYIAELLAHK 241 660.3715 1156.672 beta globin NP_000509.1 LLVVYPWTQR 242 637.8664 404.2247 beta globin NP_000509.1 LLVVYPWTQR 242 637.8664 590.304 beta globin NP_000509.1 LLVVYPWTQR 242 637.8664 850.42 beta globin NP_000509.1 LLVVYPWTQR 242 637.8664 949.4885 beta globin NP_000509.1 LLVVYPWTQR 242 637.8664 1048.557 beta globin NP_000509.1 LLVVYPWTQR 242 637.8664 1161.641 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8381 1003.541 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 375.2233 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 522.2917 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 593.3288 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 707.3717 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 794.4037 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 893.4722 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 1007.515 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 1135.574 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 1264.616 ceruloplasmin precursor NP_000087.1 ELHHLQEQNVSNAFLDK 244 1011.506 1392.675 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 357.2491 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 454.3018 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 555.3495 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 656.3972 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 769.4813 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 882.5653 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 983.613 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 1146.676 apolipoprotein B precursor NP_000375.2 LPYTIITTPPLK 245 678.9105 1243.729 apolipoprotein B precursor NP_000375.2 TGISPLALIK 246 506.8237 373.2804 apolipoprotein B precursor NP_000375.2 TGISPLALIK 246 506.8237 444.3175 apolipoprotein B precursor NP_000375.2 TGISPLALIK 246 506.8237 557.4016 apolipoprotein B precursor NP_000375.2 TGISPLALIK 246 506.8237 654.4543 apolipoprotein B precursor NP_000375.2 TGISPLALIK 246 506.8237 854.5704 apolipoprotein B precursor NP_000375.2 TGISPLALIK 246 506.8237 911.5919 pregnancy-zone protein NP_002855.1 ATVLNYLPK 247 509.8002 747.4394 serum amyloid P component precursor NP_001630.1 VGEYSLYIGR 248 578.8035 708.4034 apolipoprotein A-II preproprotein NP_001634.1 SKEQLTPLIK 249 578.8505 941.566 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 319.1607 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 416.2134 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 503.2455 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 616.3295 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 730.3724 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 843.4565 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 900.478 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 1014.521 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 1085.558 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 1232.626 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 1347.653 paraoxonase 1 NP_000437.3 VVAEGFDFANGINISPDGK 250 975.4838 1494.722 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 374.2393 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 503.2818 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 617.3248 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 745.3834 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 874.426 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 1060.505 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 1157.558 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 1270.642 apolipoprotein B precursor NP_000375.2 IVQILPWEQNEQVK 251 862.4725 1383.726 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 451.2294 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 580.272 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 679.3404 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 807.399 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 935.4576 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 1050.484 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 1163.569 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 1300.627 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 1357.649 apolipoprotein A-IV precursor NP_000473.2 SLAELGGHLDQQVEEFR 252 964.4791 1414.67 apolipoprotein E precursor NP_000032.1 FWDYLR 253 450.2242 566.2927 alpha-2-macroglobulin precursor NP_000005.2 GHFSISIPVK 254 542.8111 890.5341 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 402.2454 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 516.2883 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 645.3309 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 758.415 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 857.4834 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 956.5518 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 1069.636 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 1182.72 apolipoprotein B precursor NP_000375.2 QTIIVVLENVQR 255 706.417 1283.768 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 359.2647 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 474.2917 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 573.3601 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 736.4234 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 835.4918 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 936.5395 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 1007.577 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 1120.661 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 1235.688 apolipoprotein A-I preproprotein NP_000030.1 VKDLATVYVDVLK 256 731.9294 1363.783 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 351.2021 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 464.2862 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 535.3233 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 664.3659 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 777.45 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 878.4976 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 975.5504 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 1104.593 apolipoprotein B precursor NP_000375.2 GFEPTLEALFGK 257 654.8453 1251.661 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 387.2709 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 516.3135 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 603.3455 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 674.3826 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 771.4354 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 982.5311 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 1111.574 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 1198.606 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 1313.633 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623 1476.696 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 404.2287 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 519.2556 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 647.3142 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 760.3983 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 847.4303 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 1010.494 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 1138.552 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 1267.595 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 1338.632 apolipoprotein B precursor NP_000375.2 NLTDFAEQYSIQDWAK 259 964.9549 1485.7 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 347.2283 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 418.2655 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 505.2975 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 691.3768 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 792.4245 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 863.4616 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 977.5045 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 1140.568 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 1239.636 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 1336.689 apolipoprotein B precursor NP_000375.2 FEVDSPVYNATWSASLK 260 957.4677 1423.721 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 347.192 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 476.2346 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 577.2822 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 706.3248 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 803.3776 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 900.4304 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 999.4988 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 1112.583 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 1225.667 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 1296.704 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 1383.736 apolipoprotein B precursor NP_000375.2 GIISALLVPPETEEAK 261 833.9667 1496.82 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 343.2334 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 444.2811 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 630.3604 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 759.403 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 922.4664 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 1023.514 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 1170.582 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 1271.63 ceruloplasmin precursor NP_000087.1 SVPPSASHVAPTETFTYEWTVPK 262 1266.126 1400.673 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 347.2283 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 448.276 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 561.3601 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 674.4442 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 731.4656 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 818.4976 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 889.5347 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 960.5719 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 1089.615 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 1218.657 apolipoprotein B precursor NP_000375.2 VNWEEEAASGLLTSLK 263 873.949 1347.7 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 264 917.4496 1188.6 apolipoprotein A-IV precursor NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442 579.811 apolipoprotein C-III precursor NP_000031.1 GWVTDGFSSLK 266 598.801 854.4249 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3852 541.3451 apolipoprotein A-I preproprotein NP_000030.1 LLDNWDSVTSTFSK 268 806.8963 971.4675 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 400.2297 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 487.2618 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 650.3251 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 765.3521 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 951.4313 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 1080.474 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 1179.542 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 1308.585 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 1407.653 ceruloplasmin precursor NP_000087.1 TYYIAAVEVEWDYSPQR 269 1045.497 1478.69 apolipoprotein B precursor NP_000375.2 LAPGELTIIL 270 520.3235 358.2695 apolipoprotein B precursor NP_000375.2 LAPGELTIIL 270 520.3235 459.3172 apolipoprotein B precursor NP_000375.2 LAPGELTIIL 270 520.3235 572.4012 apolipoprotein B precursor NP_000375.2 LAPGELTIIL 270 520.3235 701.4438 apolipoprotein B precursor NP_000375.2 LAPGELTIIL 270 520.3235 758.4653 apolipoprotein B precursor NP_000375.2 LAPGELTIIL 270 520.3235 855.5181 apolipoprotein B precursor NP_000375.2 LAPGELTIIL 270 520.3235 926.5552 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 450.2124 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 565.2393 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 694.2819 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 793.3503 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 906.4344 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 1003.487 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 1132.53 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 1279.598 apolipoprotein E precursor NP_000032.1 SWFEPLVEDM[Oxid]QR 271 776.8586 1465.677 beta globin NP_000509.1 LLVVYPWTQR 272 637.8664 687.3568 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 335.192 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 422.224 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 551.2666 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 664.3506 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 751.3827 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 898.4511 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 1061.514 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 1148.546 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 1249.594 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 1362.678 apolipoprotein B precursor NP_000375.2 LSLESLTSYFSIESSTK 273 946.4804 1449.71 apolipoprotein B precursor NP_000375.2 TGISPLALIK 274 506.8237 741.4863 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 373.2804 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 430.3018 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 517.3339 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 645.3925 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 758.4765 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 873.5035 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 960.5355 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 1061.583 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 1148.615 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 1249.663 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 1362.747 apolipoprotein B precursor NP_000375.2 YEDGTLSLTSTSDLQSGIIK 275 1064.54 1449.779 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 319.1607 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 416.2134 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 503.2455 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 574.2826 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 689.3095 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 804.3364 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 917.4205 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 1064.489 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 1165.537 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 1293.595 apolipoprotein B precursor NP_000375.2 DQEVLLQTFLDDASPGDK 276 995.9838 1406.679 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 335.192 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 472.2509 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 601.2935 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 658.3149 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 772.3578 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 873.4055 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 1020.474 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 1167.542 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 1280.626 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 1337.648 apolipoprotein B precursor NP_000375.2 NHLQLEGLFFTNGEHTSK 277 1036.513 1466.69 histidine-rich glycoprotein precursor NP_000403.1 DGYLFQLLR 278 562.8086 401.2865 histidine-rich glycoprotein precursor NP_000403.1 DGYLFQLLR 278 562.8086 529.3451 histidine-rich glycoprotein precursor NP_000403.1 DGYLFQLLR 278 562.8086 789.4976 histidine-rich glycoprotein precursor NP_000403.1 DGYLFQLLR 278 562.8086 952.5609 histidine-rich glycoprotein precursor NP_000403.1 DGYLFQLLR 278 562.8086 1009.582 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 397.2076 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 544.276 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 641.3288 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 754.4128 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 901.4813 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 1014.565 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 1151.624 apolipoprotein B precursor NP_000375.2 EQHLFLPFSYK 279 704.8666 1279.683 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 374.2393 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 489.2662 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 602.3503 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 739.4092 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 810.4463 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 923.5303 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 980.5518 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 1095.579 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 1182.611 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 1329.679 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 1400.716 beta globin NP_000509.1 VLGAFSDGLAHLDNLK 280 835.449 1457.738 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 388.2549 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 501.339 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 588.371 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 701.4551 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 848.5234 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 919.5606 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 1018.629 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 1147.672 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 1234.704 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 1321.736 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 1392.773 pregnancy-zone protein NP_002855.1 ISASSEVAFLSIQIK 281 796.9484 1479.805 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 282 942.4623 868.4882 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 389.2389 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 502.323 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 631.3655 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 746.3925 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 859.4766 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 972.5607 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 1086.604 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 1157.641 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 1270.725 apolipoprotein B precursor NP_000375.2 IAIANIIDEIIEK 283 727.9269 1341.762 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 451.2294 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 538.2614 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 651.3455 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 752.3932 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 853.4409 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 910.4623 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 1023.546 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 1151.605 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 1266.632 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 1379.716 apolipoprotein B precursor NP_000375.2 VLLDQLGTTISFER 284 796.4381 1492.8 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 317.2178 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 445.2764 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 592.3448 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 679.3768 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 750.4139 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 878.4725 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 935.494 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 1064.536 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 1192.595 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 1293.643 apolipoprotein B precursor NP_000375.2 AQNLYQELLTQEGQASFQGLK 285 1183.603 1406.727 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 347.2283 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 533.3077 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 590.3291 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 689.3975 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 802.4816 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 889.5136 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 986.5664 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 1101.593 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 1248.662 apolipoprotein B precursor NP_000375.2 EEYFDPSIVGWTVK 286 835.4091 1411.725 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 357.2491 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 444.2811 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 559.308 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 672.3921 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 785.4762 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 886.5239 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 999.6079 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 1114.635 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 1185.672 apolipoprotein B precursor NP_000375.2 TLADLTLLDSPIK 287 700.4058 1298.756 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 375.2233 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 472.276 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 585.3601 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 686.4078 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 783.4605 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 896.5446 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 1010.588 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 1123.672 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 1194.709 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 1341.777 apolipoprotein B precursor NP_000375.2 TSSFALNLPTLPEVK 288 808.9484 1428.809 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 358.2079 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 445.24 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 558.324 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 686.3826 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 757.4197 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 871.4626 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 942.4998 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 1070.558 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 1217.627 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 1332.654 apolipoprotein B precursor NP_000375.2 LEVLNFDFQANAQLSNPK 289 1024.526 1479.722 histidine-rich glycoprotein precursor NP_000403.1 DGYLFQLLR 290 562.8086 676.4135 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 405.2087 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 520.2356 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 649.2782 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 796.3466 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 943.415 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 1058.442 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 1171.526 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 1284.61 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 1383.678 histidine-rich glycoprotein precursor NP_000403.1 DSPVLIDFFEDTER 291 841.899 1480.731 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 331.1971 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 460.2397 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 573.3237 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 688.3506 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 801.4347 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 872.4718 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 1001.514 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 1100.583 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 1215.61 histidine-rich glycoprotein precursor NP_000403.1 ADLFYDVEALDLESPK 292 912.9487 1378.673 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 321.1763 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 468.2447 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 583.2717 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 696.3557 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 783.3878 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 896.4718 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 953.4933 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 1024.53 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 1137.615 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 1251.657 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 1364.741 apolipoprotein B precursor NP_000375.2 FDHTNSLNIAGLSLDFSSK 293 1033.513 1451.773 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 317.2178 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 430.3018 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 517.3339 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 664.4023 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 735.4394 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 898.5027 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 969.5399 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 1082.624 pregnancy-zone protein NP_002855.1 ALLAYAFSLLGK 294 633.8765 1195.708 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 425.2137 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 482.2352 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 610.2938 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 723.3779 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 820.4306 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 949.4732 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 1036.505 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 1123.537 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 1236.621 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 1333.674 pregnancy-zone protein NP_002855.1 LEAGINQLSFPLSSEPIQGSYR 295 1203.619 1480.743 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 386.2141 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 515.2567 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 628.3408 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 791.4041 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 904.4882 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 1017.572 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 1114.625 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 1227.709 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 1340.793 pregnancy-zone protein NP_002855.1 NELIPLIYLENPR 296 792.4432 1469.836 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 347.192 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 446.2604 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 575.303 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 722.3714 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 837.3983 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 894.4198 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 1007.504 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 1120.588 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 1234.631 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 1347.715 apolipoprotein B precursor NP_000375.2 HFVINLIGDFEVAEK 297 865.9592 1446.783 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 421.2301 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 518.2828 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 631.3669 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 728.4197 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 875.4881 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 962.5201 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 1059.573 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 1206.641 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 1320.684 histidine-rich glycoprotein precursor NP_000403.1 GEVLPLPEANFPSFPLPHHK 298 1113.589 1391.721 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 403.2294 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 504.2771 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 617.3611 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 714.4139 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 813.4823 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 926.5664 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 1073.635 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 1188.662 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 1285.714 apolipoprotein B precursor NP_000375.2 ATFQTPDFIVPLTDLR 299 917.4909 1386.762 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 347.2032 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 460.2873 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 531.3244 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 659.3829 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 806.4514 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 893.4834 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 990.5361 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 1103.62 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 1202.689 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 1315.773 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 1372.794 apolipoprotein B precursor NP_000375.2 FSVPAGIVIPSFQALTAR 300 937.5303 1443.831 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 374.2393 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 431.2607 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 560.3033 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 674.3463 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 788.3892 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 889.4368 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 976.4689 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 1047.506 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 1148.554 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 1261.638 apolipoprotein B precursor NP_000375.2 NSLFFSAQPFEITASTNNEGNLK 301 1265.116 1390.68 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 319.1607 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 418.2291 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 531.3131 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 644.3972 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 743.4656 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 871.5242 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 942.5613 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 1089.63 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 1236.698 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 1333.751 pregnancy-zone protein NP_002855.1 QGIPFFAQVLLVDGK 302 816.4614 1446.835 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 375.2233 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 462.2553 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 576.2982 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 689.3823 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 790.4299 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 891.4777 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 990.5461 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 1103.63 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 1190.662 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 1353.725 apolipoprotein B precursor NP_000375.2 QTVNLQLQPYSLVTTLNSDLK 303 1188.145 1450.778 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 408.2236 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 523.2505 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 636.3346 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 750.3775 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 879.4201 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 992.5042 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 1139.573 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 1252.657 apolipoprotein B precursor NP_000375.2 TIHDLHLFIENIDFNK 304 985.0125 1389.716 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 417.2451 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 545.3036 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 646.3513 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 745.4197 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 873.4783 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 960.5103 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 1047.542 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 1160.626 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 1273.71 apolipoprotein E precursor NP_000032.1 WVQTLSEQVQEELLSSQVTQELR 305 1365.701 1402.753 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 419.2396 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 533.2825 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 646.3666 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 793.435 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 908.4619 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 1021.546 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 1134.63 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 1221.662 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 1336.689 apolipoprotein B precursor NP_000375.2 HLIDSLIDFLNFPR 306 850.462 1449.773 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 375.2233 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 503.2818 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 616.3659 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 731.3928 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 844.4769 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 973.5195 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 1102.562 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 1189.594 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 1303.637 apolipoprotein B precursor NP_000375.2 NFVASHIANILNSEELDIQDLK 307 1242.142 1416.721 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 319.1607 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 416.2134 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 544.272 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 645.3197 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 702.3411 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 815.4252 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 944.4678 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 1043.536 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 1190.605 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 1353.668 apolipoprotein A-II preproprotein NP_001634.1 AGTELVNFLSYFVELGTQPATQ 308 1193.102 1440.7 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 371.2396 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 470.308 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 585.335 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 713.3935 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 826.4776 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 925.546 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 1026.594 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 1173.662 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 1320.73 alpha-2-macroglobulin precursor NP_000005.2 VSNQTLSLFFTVLQDVPVR 309 1082.094 1433.815 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 451.2294 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 614.2927 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 743.3353 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 871.3939 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 984.478 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 1085.526 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 1214.568 apolipoprotein B precursor NP_000375.2 NQDVHSINLPFFETLQEYFER 310 1313.632 1361.637 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 389.2502 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 504.2771 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 561.2985 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 660.3669 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 789.4095 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 860.4467 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 1046.526 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 1159.61 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 1258.678 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 1355.731 ceruloplasmin precursor NP_000087.1 GPEEEHLGILGPVIWAEVGDTIR 311 1244.148 1412.753 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 317.2178 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 404.2498 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 491.2818 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 604.3659 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 751.4343 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 822.4714 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 935.5555 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 992.577 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 1106.62 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 1203.673 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 1316.757 paraoxonase 1 NP_000437.3 GIETGSEDLEILPNGLAFISSGLK 312 1230.647 1429.841 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 349.1712 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 478.2138 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 591.2979 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 690.3663 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 791.414 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 878.446 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 965.478 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 1079.521 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 1136.542 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 1283.611 serum amyloid A4; constitutive NP_006503.1 VYLQGLIDYYLFGNSSTVLEDSK 313 1312.66 1396.695 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 333.1763 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 446.2604 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 503.2818 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 616.3659 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 745.4085 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 858.4926 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 971.5766 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 1086.604 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 1157.641 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 1244.673 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 1315.71 apolipoprotein B precursor NP_000375.2 TTLTAFGFASADLIEIGLEGK 314 1077.57 1462.778 apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 333.1875 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 432.256 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 560.3145 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 746.3939 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 833.4259 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 904.463 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 1032.522 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 1160.58 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 1231.617 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 1318.649 SAR apolipoprotein B precursor NP_000375.2 IDFLNNYALFLSPSAQQASWQV 315 1413.714 1415.702 SAR apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 347.2283 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 444.2811 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 557.3652 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 686.4078 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 799.4918 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 900.5395 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 1028.598 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 1157.641 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 1254.693 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 1353.762 apolipoprotein B precursor NP_000375.2 IADFELPTIIVPEQTIEIPSIK 316 1233.691 1466.846 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 371.2396 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 508.2985 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 621.3826 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 720.451 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 817.5037 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 930.5878 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 1059.63 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 1172.714 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 1259.746 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 1356.799 apolipoprotein B precursor NP_000375.2 VPSYTLILPSLELPVLHVPR 316 1122.162 1469.883 apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 363.1869 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 420.2083 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 533.2924 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 646.3765 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 761.4034 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 832.4406 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 946.4835 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 1059.568 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 1188.61 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 1301.694 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 1358.716 DK apolipoprotein B precursor NP_000375.2 FFSLLSGSLNSHGLELNADILGT 317 1324.682 1495.775 DK ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 395.2283 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 508.3124 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 623.3394 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 736.4234 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 793.4449 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 880.4769 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 977.5297 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 1048.567 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 1211.63 ceruloplasmin precursor NP_000087.1 HYYIAAEEIIWNYAPSGIDIFTK 318 1357.679 1325.673 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 390.209 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 503.2931 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 689.3724 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 802.4564 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 915.5405 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 986.5776 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 1114.636 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 1215.684 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 1328.768 alpha-2-macroglobulin precursor NP_000005.2 AYIFIDEAHITQALIWLSQR 319 1194.639 1465.827 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 374.2393 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 489.2662 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 618.3088 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 731.3928 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 844.4769 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 972.5355 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 1119.604 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 1232.688 apolipoprotein B precursor NP_000375.2 NLQDLLQFIFQLIEDNIK 320 1102.602 1379.756 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 402.2454 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 517.2723 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 646.3149 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 759.399 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 872.483 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 985.5671 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 1072.599 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 1201.642 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 1315.685 ceruloplasmin precursor NP_000087.1 EFYLFPTVFDENESLLLEDNIR 321 1352.163 1444.727 apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 289.1865 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 402.2705 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 503.3182 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 689.3975 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 875.4769 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 990.5038 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 1077.536 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 1190.62 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 1353.683 AAK apolipoprotein B precursor NP_000375.2 YLSLVGQVYSTLVTYISDWWTL 322 1439.257 1454.731 AAK apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 373.2804 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 502.323 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 603.3707 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 716.4547 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 879.5181 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 992.6021 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 1105.686 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 1252.755 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 1353.802 apolipoprotein B precursor NP_000375.2 LIDLSIQNYHTFLIYITELLK 323 1275.714 1490.861 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 417.2451 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 564.3135 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 661.3662 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 774.4503 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 875.498 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 988.582 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 1087.651 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 1200.734 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 1315.761 apolipoprotein B precursor NP_000375.2 VHNGSEILFSYFQDLVITLPFELR 324 1419.247 1443.82 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 374.2393 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 489.2662 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 604.2932 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 717.3772 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 880.4406 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 1066.52 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 1153.552 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 1282.594 ceruloplasmin precursor NP_000087.1 LEFALLFLVFDENESWYLDDNIK 325 1417.202 1396.637
Example 2
Mass Spectrometry Methods for Determining Expression Levels of Pre-Selected Biomarkers that are Predictive of Trisomy 21 Pregnancies During the First Trimester
Materials and Methods
Clinical Serum Samples
[0077] The clinical samples used in this Example are as described herein in Example 1.
[0000] Serum Processing without Enrichment
[0078] Serum samples without enrichment were prepared by diluting serum 1:4 v/v with 8M GuHC1/150 mM Tris/10 mM DTT pH 8.5. Samples were incubated at 37° C. for 60 minutes and then cooled to room temperature. Next, 500 mM iodoacetic acid/1M Tris pH 8.5 was added to each sample to a final concentration of 40 mM. Samples were alkylated in the dark at room temperature for 60 minutes. The reaction was quenched with the addition of 2 M DTT to a final concentration of 5 mM. Post quench, samples were diluted to 1 ml with the addition of 50 mM Tris/5 mM CaCl2, pH 8.0 and 10 μg of sequencing grade trypsin (Promega) were added to each sample prior to incubation at 37° C. for 24 hours. The digestion reaction was quenched with the addition of TFA to 1%. Subsequent to digestion, the samples were processed by solid phase extraction for desalting and clean-up using Hypersep™ C18 50 mg 96 well plates (ThermoFisher). Plates were equilibrated once with 100% ACN and then rinsed twice with 0.25% TFA. Samples were then loaded and wells were rinsed 5 times with 0.25% TFA. The peptides were eluted with 400 μl of 75% ACN/0.1% formic acid at 300 rcf in a centrifuge equipped with a swinging bucket rotor. After elution, the samples were lyophilized. Just before loading on the mass spectrometer, peptides were resuspended in 97% H2O/3% ACN/0.25% formic acid.
High Resolution LC-MS/MS
[0079] High resolution LC-MS/MS analysis was carried out as described herein in Example 1.
Selective Reaction Monitoring (SRM) Assays
[0080] SRM assays were performed as described herein in Example 1.
Results
[0081] Using the techniques described above, the expression levels of 171 peptide fragments representing 19 target proteins were shown to be differentially expressed in first trimester maternal serum samples from Trisomy 21 pregnancies relative to normal pregnancies. The amino acid sequences, m/z transitions and parent target protein for each of the identified peptides are shown in Table 2.
[0000] [00002] NCBI SEQ Accession Amino Acid Sequence ID Parent Peptide Fragment Fragmentation Protein Name No. of Peptide Fragment NO: m/z Ion Ion m/z Energy paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 868.4882 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 982.5311 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 603.3455 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 771.4354 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 1198.606 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 1313.633 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 812.3858 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 387.2709 35.35772 paraoxonase 1 NP_000437.3 IFFYDSENPPASEVLR 258 942.4623413 516.3135 35.35772 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 747.4394 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 846.5078 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 244.165 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 634.3553 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 423.7575 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 357.2491 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 520.3124 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 474.2814 20.64721 pregnancy-zone protein NP_002855.1 ATVLNYLPK 175 509.8002319 179.1282 20.64721 alpha-2-macroglobulin NP_000005.2 GHFSISIPVK 254 542.8110962 890.5341 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 343.2334 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 743.4656 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 656.4336 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 456.3175 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 514.3001 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 543.3495 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 372.2365 21.76958 precursor alpha-2-macroglubulin NP_000005.2 GHFSISIPVK 254 542.8110962 328.7204 21.76958 precursor serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 634.2972 22.58433 constitutive serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 535.2288 22.58433 constitutive serum amyloid A4; NP-006503.1 EALQGVGDMGR 98 566.7744141 691.3187 22.58433 constitutive serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 466.7343 22.58433 constitutive serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 363.1804 22.58433 constitutive serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 819.3772 22.58433 constitutive serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 478.2073 22.58433 constitutive serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 410.1922 22.58433 constitutive serum amyloid A4; NP_006503.1 EALQGVGDMGR 98 566.7744141 232.1399 22.58433 constitutive serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 708.4034 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 508.2873 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 871.4667 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 621.3713 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 345.2239 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 232.1399 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 1057.531 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 1000.509 22.99332 precursor serum amyloid P component NP_001630.1 VGEYSLYIGR 177 578.8034668 436.237 22.99332 precursor beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 687.3568 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 850.42 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 949.4885 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 425.7137 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 1048.557 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 524.7821 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 475.2479 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 303.177 25.00146 beta globin NP_000509.1 LLVVYPWTQR 242 637.866394 404.2247 25.00146 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 540.824 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 670.3877 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 870.5038 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 622.3556 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 1080.641 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 783.4717 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 983.5878 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 331.2083 26.6511 ceruloplasmin precursor NP_000087.1 GAYPLSIEPIGVR 267 686.3851929 541.3451 26.6511 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 711.8596 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 785.3938 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 442.5579 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 523.9316 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 663.3332 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 474.9088 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 589.3298 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 611.968811 463.7561 30.24063 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.449585 1041.532 34.50729 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.449585 926.5049 34.50729 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.449585 813.4208 34.50729 alpha 1 globin NP_000549.1 TYFPHFDLSHGSAQVK 221 917.449585 1188.6 34.50729 histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 676.4135 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 789.4976 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 529.3451 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 288.2025 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 401.2865 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 201.1469 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 476.7841 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 395.2524 22.44949 precursor histidine-rich glycoprotein NP_000403.1 DGYLFQLLR 278 562.8085938 338.7104 22.44949 precursor 3 apolipoprotein H precursor 3 NP_000033.1 ATVVYQGER 45 511.7669067 652.3044 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 751.3728 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 425.7242 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 361.1825 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 850.4412 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 489.241 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 304.161 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 326.6558 20.71407 apolipoprotein H precursor NP_000033.1 ATVVYQGER 45 511.7669067 376.19 20.71407 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 741.4863 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 654.4543 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 854.5704 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 427.7888 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 260.1963 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 327.7308 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 373.2804 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 444.3175 20.54601 apolipoprotein B precursor NP_000375.2 IGISPLALIK 246 506.8237 911.5919 20.54601 apolipoprotein E precursor NP_000032.1 FWDYLR 253 450.2241516 566.2927 18.62162 apolipoprotein E precursor NP_000032.1 FWDYLR 253 450.2241516 752.3721 18.62162 apolipoprotein E precursor NP_000032.1 FWDYLR 253 450.2241516 288.2025 18.62162 apolipoprotein E precursor NP_000032.1 FWDYLR 253 450.2241516 376.6897 18.62162 apolipoprotein E precursor NP_000032.1 FWDYLR 253 450.2241516 451.2658 18.62162 apolipoprotein E precursor NP_000032.1 FWDYLR 253 450.2241516 226.1365 18.62162 apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 971.4675 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 670.3401 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 856.4406 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 569.2924 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 1386.617 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 1157.547 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 769.4085 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 1271.59 30.74847 preproprotein apolipoprotein A-I NP_000030.1 LLDNWDSVTSTFSK 268 806.8963013 482.2604 30.74847 preproprotein apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 854.4249 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 953.4933 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 753.3772 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 638.3503 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 434.2604 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 581.3288 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 347.2283 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 477.2503 23.67323 precursor apolipoprotein C-III NP_000031.1 GWVTDGFSSLK 226 598.8009644 260.1963 23.67323 precursor apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 1052.489 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 923.4464 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 776.3779 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 590.7956 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 262.1392 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 719.3564 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 504.2659 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 388.6926 25.32349 apolipoprotein C-I precursor NP_001636.1 LKEFGNTLEDK 233 647.3378906 605.3135 25.32349 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 1003.541 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 890.4572 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 789.4095 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 361.2076 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 246.1807 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 502.2743 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 588.3346 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 702.3775 24.25249 apolipoprotein D precursor NP_001638.1 NILTSNNIDVK 243 615.8380737 474.2917 24.25249 apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 941.566 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 470.3332 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 812.5234 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLTK 249 578.8504639 684.4649 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 471.2867 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 260.1963 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 535.3342 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 373.2804 22.99492 preproprotein apolipoprotein A-II NP_001634.1 SKEQLTPLIK 249 578.8504639 286.1941 22.99492 preproprotein apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 579.811 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 536.3073 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 545.9422 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 736.4234 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 701.3538 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 564.9493 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 465.7555 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 623.3394 29.83035 precursor apolipoprotein A-IV NP_000473.2 LGPHAGDVEGHLSFLEK 265 602.6442261 769.8832 29.83035 precursor apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 620.3033 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 870.3987 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 783.3666 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 434.224 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 957.4307 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 305.1814 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 1070.515 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAK 161 643.798584 535.761 25.20315 apolipoprotein C-II precursor NP_000474.2 ESLSSYWESAKI 161 643.7985844 35.703 25.20315
[0082] The relevant teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety.
[0083] While this invention has been particularly shown and described with references to example embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.


  • US20100216250A1-20100826-D00000
  • US20100216250A1-20100826-D00001
  • US20100216250A1-20100826-D00002
Keywords
Similar
Note
Team Comments
More Comment

Original Text
Translate